Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1040101-1065572 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" Translocase "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 26.7;HMC-1: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: AB_2677550" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (7.26e-4)" "prognostic favorable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 6.0 3.5 6.2 20.2 4.8 35.2 7.6 13.6 11.1 5.0 5.8 1.9 4.7 4.9 2.1 3.9 7.5 2.8 5.5 2.3 5.3 6.5 5.3 3.6 9.5 17.7 5.2 5.1 1.0 7.0 5.6 34.5 3.1 7.7 4.9 4.2 34.7 9.9 6.5 5.5 11.1 11.1 1.8 6.7 26.6 7.9 1.6 4.3 19.8 7.0 3.9 14.5 5.1 4.9 1.5 9.9 10.8 2.5 1.9 2.6 1.2 5.7 5.4 1.1 3.4 6.7 3.0 5.6 0.8 0.8 0.3 0.6 4.1 2.2 11.2 3.8 0.8 0.4 5.7 2.3 5.1 0.3 7.4 2.1 8.6 26.7 4.1 2.6 3.2 32.2 2.8 1.8 1.5 2.9 5.5 1.9 6.1 8.7 7.0 1.0 1.4 3.1 2.3 0.6 4.2 2.5 2.9 0.6 8.0 2.8 10.8 0.7 2.2 6.3 1.9 0.6 2.5 3.7 5.2 2.8 0.6 1.4 2.9 0.8 8.1 7.9 6.1 1.4 7.7 1.3 4.3 2.5 7.0 2.6 1.7 1.6 1.0 1.5 1.8 2.8 1.5 1.4 2.1 10.8 1.9 1.6 9.9 0.6 1.2 6.2 4.8 13.6 11.1 5.3 6.5 5.2 5.1 7.7 4.3 68.5 31.1 10.2 0.6 3.0 64.0 5.6 2.5 5.3 9.1 5.2 164.9 2.4 1.7 2.7 6.0 2.9 9.0 0.0 2.1 217.5 2.8 1.4 9.3 3.2 6.9 14.3 3.4 3.1 14.8 2.9 0.0 7.0 0.0 10.0 3.8 13.0 5.9 10.5 0.0 1.3 151.3 0.0 3.1 0.7 1.9 3.0 21.5 10.2 2.9 1.7 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.1 9.4 11.2 9.4 10.7 14.6 6.0 4.7 5.4 5.9 6.3 5.7 8.0 14.1 5.7 8.2 29.9 11.6 6.6 7.1 8.7 11.2 16.9 10.3 5.7 3.9 5.1 13.2 17.0 6.7 5.8 3.8 11.1 6.3 23.7 15.7 11.1 9.2 19.5 14.1 5.9 9.7 13.4 7.9 9.8 3.1 4.7 19.6 48.0 17.2 10.2 6.1 33.9 10.1 12.7 20.5 1.6 7.2 6.3 6.2 8.0 8.2 4.3 8.3 7.4 4.6 10.3 6.4 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 8.9 4.0 1.9 12.9 7.9 34.3 31.9 2.5 56.2 46.6 41.8 184.6 2.7 6.6 5.0 4.8 6.7 9.5 0.0 4.0 3.9 8.0 10.9 4.7 2.4 39.9 31.8 56.9 5.5 27.9 2.2 7.5 11.2 11.8 6.4 6.3 9.4 6.1 9.3 7.4 2.7 122.3 0.0 8.6 3.1 14.7 10.7 3.8 5.0 7.2 50.3 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 57.0;Hepatocytes: 97.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.2 1.5 0.0 0.0 13.1 25.1 0.0 5.1 14.3 2.9 5.1 0.0 5.1 0.0 0.8 6.4 15.6 0.1 0.0 5.9 5.8 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 29.6 1.6 10.5 29.6 24.8 13.1 0.0 0.0 2.3 17.0 2.8 0.0 0.0 0.0 0.4 20.1 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.7 0.4 0.4 0.0 32.8 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 0.0 3.0 4.7 1.0 1.3 1.1 57.0 28.1 4.0 1.2 0.0 0.0 0.1 5.0 6.8 1.8 20.2 0.0 0.0 3.0 0.6 2.1 2.2 1.1 97.0 9.3 27.0 0.0 20.3 11.9 0.0 0.3 0.8 5.0 0.0 0.0 19.7 14.9 0.0 0.7 18.3 21.8 0.0 2.3 1.7 2.3 1.4 0.3 0.0 0.0 4.9 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924" "prognostic unfavorable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 18.9 5.9 41.5 14.8 4.0 3.4 30.9 7.7 4.0 6.7 8.3 25.3 11.9 3.4 14.3 4.6 10.5 9.1 17.2 15.8 12.0 21.4 17.8 0.1 2.5 19.1 6.1 2.1 9.1 2.4 10.7 11.2 26.5 10.7 12.3 7.4 38.0 13.3 4.3 8.1 0.2 0.1 10.1 27.1 2.7 12.3 10.9 14.4 12.2 9.3 19.2 11.7 7.8 29.8 11.8 40.5 3.5 0.8 18.0 3.1 15.1 13.4 12.7 0.2 16.1 6.9 9.3 4.4 27.2 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 157.8 72.9 0.0 0.0 0.0 0.0 0.0 0.0 85.6 75.1 90.7 0.0 27.0 18.3 58.2 0.0 0.0 0.0 0.0 34.2 28.5 0.0 0.0 8.1 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.0 0.0 0.0 52.1 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell type enriched" "Detected in many" 18 "Alveolar cells type 1: 2224.3" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.2 1.9 2.7 0.1 0.2 0.1 0.2 0.1 0.4 0.2 2.1 0.5 0.0 2.2 0.2 1.1 0.3 0.4 4.9 1.3 0.1 0.0 0.0 0.6 2.2 0.3 0.3 0.1 0.2 0.3 0.3 8.1 0.0 0.8 0.2 4.2 0.3 1.5 0.0 0.2 0.0 0.1 0.2 0.3 5.1 0.1 0.1 0.5 0.1 0.0 1.9 0.1 1.2 0.1 0.2 0.0 1.5 1.5 0.1 6.1 3.2 2.2 2.2 0.5 0.5 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 2224.3 120.3 1.7 1.1 0.8 4.8 3.4 5.1 8.1 37.5 1.8 0.0 0.9 0.0 1.5 0.0 2.6 0.5 0.0 0.8 0.8 1.6 2.3 16.3 1.8 1.2 6.4 0.0 2.5 9.0 0.2 1.7 4.9 1.7 2.8 1.4 7.4 0.8 2.9 1.1 0.2 4.1 6.5 1.7 0.0 0.7 1.6 1.8 5.0 0.9 0.8 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161" 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 0.0 2.9 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 2.2 1.5 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 3.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 9.4;Club cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" NA NA "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: AB_2685449" "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.8 6.1 10.6 16.2 17.7 7.1 10.6 6.2 9.3 1.2 8.0 4.8 5.7 7.0 7.0 3.7 2.7 12.6 8.9 10.1 4.8 4.2 3.0 5.5 8.3 2.5 8.3 16.7 17.1 7.4 7.7 11.6 6.9 6.4 4.1 8.1 7.1 3.1 4.3 6.5 3.1 1.9 2.9 2.6 6.2 6.6 4.8 6.4 7.8 6.1 5.4 4.3 8.4 9.3 6.5 4.2 8.6 2.5 3.0 4.0 5.1 16.0 11.5 4.1 6.2 4.1 7.2 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 3.0 8.6 26.7 25.9 14.1 25.6 7.7 35.7 16.0 12.5 17.4 9.8 22.6 23.2 10.6 0.9 12.1 16.1 23.3 14.6 18.8 13.1 25.9 18.5 19.5 9.2 22.3 23.2 16.0 16.2 1.7 30.2 11.1 11.8 12.6 19.4 15.6 14.7 18.4 27.3 14.0 21.5 25.8 14.4 23.0 15.1 10.8 40.8 18.1 16.2 31.3 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723668 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.8" "Cell type enhanced" "Detected in all" 7 "Muller glia cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: AB_2683546" "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 19.6 13.6 34.5 7.1 38.5 4.7 15.6 37.9 39.3 16.2 12.0 39.1 4.4 9.4 14.8 6.0 8.4 14.0 13.5 15.0 43.1 25.2 8.5 9.8 15.7 3.5 42.3 24.0 25.5 11.0 12.4 9.7 12.1 27.3 8.2 14.1 6.7 16.0 9.1 10.9 4.7 11.5 13.7 54.8 6.0 19.5 10.4 43.7 2.7 9.8 3.7 4.2 9.2 9.3 0.2 1.6 3.6 1.9 1.0 2.0 1.0 23.0 10.2 25.1 21.3 17.7 25.6 8.6 16.6 11.0 10.2 14.4 7.4 14.7 4.3 5.7 26.3 15.8 15.3 13.2 16.6 15.0 14.1 8.4 25.3 22.0 5.3 10.6 0.0 3.9 10.4 18.2 13.3 14.5 15.2 17.5 6.5 10.7 38.8 20.0 4.5 12.0 0.8 3.8 8.3 5.5 2.6 8.9 2.4 6.9 4.1 4.3 4.4 11.3 6.3 13.5 7.7 6.6 3.6 19.3 14.7 9.4 16.0 11.9 4.3 7.6 3.0 15.1 4.4 9.8 3.6 0.8 1.6 0.5 1.9 0.4 0.2 0.6 1.6 1.3 0.0 2.0 1.2 0.1 1.0 0.9 1.6 1.0 1.0 34.5 38.5 37.9 36.1 43.1 25.2 42.3 24.0 27.3 43.7 80.4 22.0 5.2 10.4 26.3 127.8 32.7 20.4 34.8 61.4 5.2 64.8 19.4 1.7 18.9 4.3 25.3 34.0 23.3 23.9 15.9 47.4 17.6 16.2 18.7 12.1 125.5 15.5 20.9 25.3 5.3 86.0 24.4 18.6 7.2 26.8 217.5 27.9 26.0 55.9 5.7 53.2 25.8 19.4 25.1 33.0 17.7 10.5 10.0 23.4 24.0 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883945-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 46.4;Syncytiotrophoblasts: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: AB_2685131" "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 22.0 19.9 13.4 13.1 10.5 2.2 20.1 15.7 22.4 29.9 15.6 5.9 8.7 13.9 32.2 9.9 13.2 12.7 20.5 20.1 19.7 13.2 23.9 12.8 14.4 13.9 11.3 11.2 9.8 7.8 3.5 28.0 31.4 12.3 14.3 15.4 15.3 19.6 12.1 5.2 16.9 12.7 26.7 15.1 15.2 11.1 14.2 10.5 17.4 13.4 13.9 10.8 19.1 13.6 2.0 5.0 7.4 3.5 1.4 4.8 2.3 1.9 3.9 6.0 10.1 6.0 5.3 7.5 6.3 9.5 6.3 13.5 14.9 4.9 17.4 10.3 6.1 7.1 4.8 9.0 10.3 8.9 2.3 9.4 24.0 5.5 1.3 1.5 2.3 28.1 7.5 7.1 10.4 7.2 10.1 15.2 4.5 21.5 2.8 4.1 4.2 4.4 2.2 2.0 0.8 2.5 4.0 6.4 0.4 8.9 21.0 7.6 3.9 8.0 4.4 5.0 12.1 4.8 2.9 7.7 3.9 6.1 2.9 4.5 1.1 1.1 19.9 6.0 6.4 6.4 2.7 3.5 4.6 2.9 3.2 1.7 2.0 2.0 2.1 5.0 1.6 2.1 1.7 7.4 1.4 2.3 0.7 4.8 2.3 13.4 10.5 15.7 22.4 19.7 13.2 11.3 11.2 12.3 10.5 3.0 7.7 0.9 6.9 8.7 5.0 6.3 7.6 4.0 3.4 12.2 13.7 46.4 18.3 2.8 1.8 27.5 4.9 0.0 4.2 2.6 5.0 4.8 2.3 4.0 7.5 1.6 20.1 17.8 7.6 1.1 4.0 7.4 1.7 0.0 6.7 2.8 5.6 8.2 3.5 5.7 2.8 6.5 3.5 0.7 2.8 8.8 35.7 4.3 6.6 6.0 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 11.1;U-266/70: 11.2" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.5 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.4 0.5 0.0 0.5 0.6 0.7 0.6 0.3 0.5 2.5 1.1 0.1 0.3 2.3 0.0 0.2 0.0 2.3 0.7 3.7 0.6 0.4 3.2 0.2 2.0 0.6 3.1 0.7 0.4 0.0 0.0 11.1 3.3 0.9 0.9 0.0 0.2 0.0 1.1 2.0 0.0 0.9 0.1 0.3 0.6 0.3 0.7 1.2 5.7 0.4 11.2 1.7 5.6 2.4 2.7 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8orf37 "BBS21, CORD16, FLJ30600, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244919-95269201 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 4.8 5.6 7.9 5.8 9.9 2.4 6.4 9.8 8.0 6.7 3.1 10.5 2.9 2.6 6.5 8.6 3.3 10.5 4.0 7.0 8.7 7.1 6.6 4.9 4.3 5.6 7.4 6.9 13.0 3.8 10.1 9.9 4.9 7.9 5.6 2.8 4.6 4.3 7.1 2.9 4.2 3.3 6.2 9.2 4.4 3.2 4.5 9.5 3.8 6.7 1.6 5.1 4.0 4.4 3.9 1.9 2.3 1.4 2.7 2.3 0.8 4.0 6.7 5.5 2.9 1.9 5.2 1.6 1.8 4.1 2.3 3.1 1.0 9.0 8.2 4.3 3.0 5.8 3.4 2.3 4.6 5.1 2.6 2.1 6.4 4.0 3.0 2.2 1.3 3.6 5.2 2.2 2.7 7.7 6.0 3.5 4.9 3.3 4.8 3.0 3.1 6.8 1.6 1.7 8.3 4.6 3.6 2.9 2.1 5.1 1.8 5.4 5.2 3.7 0.7 3.1 4.3 6.4 1.2 2.9 2.9 3.7 2.5 1.8 4.4 4.2 5.5 5.6 3.1 3.6 1.3 1.4 0.6 1.2 0.9 2.1 1.9 1.4 1.3 1.9 3.9 1.4 2.3 2.3 2.7 0.7 0.9 0.5 0.8 7.9 9.9 9.8 8.0 8.7 7.1 7.4 6.9 7.9 9.5 3.0 1.6 0.8 3.1 0.8 1.6 3.9 0.0 9.4 4.5 7.0 2.0 2.0 6.6 1.5 8.2 1.0 0.0 0.0 2.4 2.4 2.2 1.7 0.0 3.2 1.2 3.2 0.0 1.3 1.6 8.0 2.8 1.1 1.7 2.8 0.0 5.7 1.0 0.0 2.8 3.7 3.6 0.0 2.1 4.4 3.6 1.6 0.7 0.0 0.4 1.0 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.3 7.0 12.2 12.4 1.9 2.7 1.7 5.3 5.3 14.9 6.9 25.4 5.4 9.4 4.6 3.4 20.4 6.0 7.4 3.5 5.8 4.2 4.1 11.0 3.7 6.1 3.4 4.4 5.7 1.7 4.0 4.3 1.6 2.6 3.4 12.3 2.8 8.3 3.3 11.5 11.6 3.5 4.0 9.4 8.1 16.1 10.3 4.1 2.2 6.2 6.6 10.2 7.8 10.4 2.1 4.8 7.0 6.8 3.5 13.8 4.2 18.1 5.5 8.0 6.5 11.2 12.4 5.1 7.2 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 3.0 1.7 2.2 0.5 0.8 6.4 6.7 0.0 0.0 3.4 0.0 3.9 0.9 1.7 1.7 33.1 1.5 1.5 0.0 2.0 0.5 2.1 0.9 0.0 1.5 1.7 12.7 3.4 1.8 2.4 16.4 1.7 1.5 0.0 0.0 3.3 1.6 1.9 2.9 3.2 0.7 2.9 0.0 0.9 16.7 7.3 1.8 1.9 0.0 2.5 0.5 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 9.6 0.0 0.1 0.2 0.3 2.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 0.0 0.0 0.0 0.0 3.1 0.1 11.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.2 1.3 0.2 0.0 0.0 0.0 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell type enriched" "Detected in many" 11 "Bipolar cells: 838.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.8 0.0 1.1 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.2 0.1 0.0 2.4 0.1 0.9 0.1 0.0 0.0 42.0 2.2 0.2 0.0 0.0 0.1 1.9 0.2 0.2 0.2 0.4 0.2 0.0 0.5 0.4 0.1 0.2 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 0.0 0.0 0.0 27.8 1.0 838.1 74.9 2.5 0.0 0.0 0.0 43.2 0.0 8.3 0.0 0.8 0.6 0.0 0.0 0.0 0.1 0.4 2.6 4.6 4.4 0.2 57.2 39.0 0.0 1.2 2.1 1.7 0.0 1.7 0.0 0.0 14.1 0.1 0.0 0.0 0.8 46.7 0.0 0.9 0.0 1.7 0.4 0.2 0.0 0.0 0.7 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.5 16.1 5.4 35.2 67.4 5.7 34.1 22.8 13.4 11.6 9.8 4.1 20.9 5.0 23.7 17.0 0.5 10.0 5.3 13.7 8.0 2.5 0.0 5.3 11.2 17.9 0.0 0.0 43.0 7.3 10.4 25.8 21.3 11.9 2.6 0.8 9.3 25.3 3.9 2.1 0.8 2.3 13.9 5.4 4.0 18.9 0.1 13.7 9.9 4.3 4.4 4.6 6.9 4.6 14.0 0.1 5.6 7.1 35.5 8.4 15.1 6.7 7.3 3.6 17.9 18.3 1.3 16.7 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 38.7 29.9 22.6 16.0 16.4 72.0 243.3 58.6 20.1 28.4 27.9 82.5 0.4 5.0 6.4 2.9 29.8 57.0 0.0 17.5 0.4 34.7 31.3 9.3 49.4 15.8 68.3 99.5 19.6 16.8 4.5 18.7 21.0 5.0 2.8 82.1 41.3 11.4 45.6 18.7 17.7 71.5 6.5 33.3 2.9 4.4 27.9 0.9 17.5 41.1 16.3 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Cell line enhanced" "Detected in all" "PC-3: 46.3;SK-BR-3: 58.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 11.1 8.0 7.3 13.9 5.3 8.7 8.6 7.6 13.2 10.6 8.7 12.5 12.0 8.2 8.1 9.8 4.1 17.4 5.7 6.5 8.4 7.5 6.8 5.6 6.2 5.6 2.6 7.6 9.5 4.6 5.9 10.5 7.3 16.3 9.0 10.6 6.1 12.4 5.8 7.8 12.7 11.4 5.3 6.8 46.3 11.6 7.6 4.3 5.5 16.2 3.8 8.8 4.4 58.3 3.7 5.6 10.9 4.8 11.0 7.9 12.7 4.2 10.3 3.8 4.5 7.7 8.4 21.9 2.8 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 14.9 9.4 11.5 7.6 8.4 55.8 6.1 15.3 6.7 9.1 7.0 94.2 130.5 11.6 10.6 1.9 18.0 50.5 0.0 17.2 36.6 11.5 7.3 16.1 7.8 22.8 25.4 23.0 12.3 13.6 2.3 11.8 10.5 11.8 5.4 20.0 16.3 16.9 51.8 17.7 27.0 74.1 45.3 50.6 0.5 10.6 11.0 67.9 22.4 26.2 10.7 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.6;MOLT-4: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.1 0.0 1.6 0.1 0.1 0.2 1.2 0.3 0.9 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 32.6 0.5 0.0 0.0 0.8 0.0 32.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 1.1 0.0 4.9 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 3.0 8.5 0.0 0.1 14.8 0.4 12.3 2.5 0.0 0.0 3.5 2.0 0.2 0.0 0.2 10.9 214.1 0.0 0.0 0.2 0.3 22.6 0.2 1.1 0.5 0.3 0.0 0.0 81.0 0.3 4.2 135.4 2.2 16.9 0.0 0.0 0.3 0.2 0.0 115.6 0.0 0.0 6.5 4.1 0.7 0.5 11.3 0.1 0.0 0.0 0.3 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737225-68835548 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 125.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "myeloid DC: 2.8;plasmacytoid DC: 8.5" "Lineage enriched" "Detected in single" 18 "dendritic cells: 8.5" "Cell line enhanced" "Detected in some" "BEWO: 107.1;CACO-2: 36.0;CAPAN-2: 50.3;HaCaT: 48.6;hTCEpi: 34.3;MCF7: 29.7;OE19: 31.7;RT4: 37.0;T-47d: 32.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA 22000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.1 0.7 1.3 14.8 1.5 0.5 15.3 0.8 1.1 14.4 63.8 1.8 42.4 25.5 4.7 18.6 48.5 9.7 48.9 0.8 1.5 1.0 24.2 64.9 24.4 0.5 1.8 0.9 5.6 71.5 62.2 13.2 55.2 2.8 28.9 25.9 11.8 66.6 43.7 0.8 30.5 125.5 1.5 1.1 3.5 21.6 2.1 1.8 11.7 83.0 26.2 32.6 16.8 21.7 0.0 8.5 0.0 0.0 0.3 0.4 0.1 21.6 2.2 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.0 36.0 50.3 0.0 0.4 0.0 0.0 48.6 0.0 24.1 0.0 4.2 0.6 0.0 0.1 7.7 0.0 0.0 0.2 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.1 0.8 31.7 0.1 0.0 0.0 0.3 8.8 37.0 1.3 0.1 0.2 0.0 9.1 15.2 32.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.8 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.1 0.1 1.3 1.5 0.8 1.1 1.5 1.0 1.8 0.9 2.8 1.8 122.1 58.7 0.9 101.9 83.6 0.0 0.8 152.8 73.6 64.8 155.3 0.0 97.3 1.7 107.7 0.0 1.2 202.1 0.0 98.3 22.3 4.1 170.0 1.1 44.7 10.1 0.0 83.2 0.6 1.5 0.0 0.3 6.3 50.6 5.4 180.9 0.0 193.9 160.9 0.4 3.3 0.0 0.0 4.7 0.0 0.1 114.9 42.2 0.0 125.1 204.2 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.7 14.1 13.2 21.5 14.6 10.7 6.6 7.8 12.8 15.3 12.6 10.0 11.0 11.6 27.9 9.6 22.8 8.4 21.2 11.8 7.0 9.1 12.6 12.7 12.4 9.9 9.6 10.2 23.9 11.6 8.9 12.6 3.9 21.4 10.3 18.2 12.9 8.5 15.3 22.7 27.6 21.0 14.5 18.9 22.3 13.5 5.4 12.9 13.3 8.9 8.4 35.9 11.2 13.8 14.7 12.6 6.4 9.0 8.7 15.1 3.9 11.3 14.5 19.7 21.5 4.5 23.7 14.8 27.0 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 0.0 5.9 11.5 6.4 3.2 11.5 3.2 7.6 8.1 7.9 10.4 2.0 20.0 33.2 19.0 0.6 6.3 7.1 0.0 16.6 10.2 6.6 5.0 31.0 9.6 37.8 0.0 8.6 6.2 21.6 0.9 4.4 14.3 10.1 20.8 9.1 11.5 18.7 14.4 10.6 24.0 4.7 6.5 5.0 2.6 9.7 5.5 7.6 8.5 9.6 7.6 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Group enriched" "Detected in many" 8 "Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" NA NA 879000000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favorable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.1 6.0 0.0 0.0 0.3 1.6 0.6 0.0 7.1 0.1 5.3 11.6 0.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.6 0.0 0.7 0.1 19.1 0.1 0.9 0.6 0.6 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.0 0.1 0.2 0.4 0.2 1.7 0.0 0.0 0.0 0.6 1.2 0.2 0.0 0.0 0.2 0.0 0.2 0.5 0.3 0.4 0.6 1.9 0.5 3.2 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 0.0 20.0 14.0 0.7 0.7 0.1 0.4 20.4 24.1 40.9 5.2 0.0 0.0 3.3 523.0 0.0 2.4 5.0 0.0 173.6 0.1 6.0 9.0 0.0 158.3 0.8 0.0 2.4 11.6 13.2 0.0 2.6 1.2 0.0 31.5 6.7 0.8 492.1 11.8 0.0 11.2 0.7 0.0 3.8 0.1 0.0 1.6 1.4 1.9 11.2 1.8 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 109.4;Cytotrophoblasts: 115.8;Hofbauer cells: 118.9;Syncytiotrophoblasts: 93.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.7;BJ: 8.6;HSkMC: 14.6;U-2197: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" NA NA 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: AB_2680208, HPA071056: AB_2686338" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.7 17.7 0.6 8.6 3.0 1.2 2.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.8 0.0 0.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.1 2.2 0.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 3.0 109.4 0.0 2.9 3.7 6.1 3.6 0.0 2.7 19.4 3.5 9.8 115.8 0.0 0.1 7.2 3.1 0.0 0.0 0.0 4.3 47.7 8.6 12.8 0.2 118.9 6.4 15.1 1.8 4.1 16.7 57.0 17.9 1.7 27.1 0.2 63.6 0.3 0.0 6.7 0.0 10.8 0.0 1.9 1.1 1.2 3.3 93.0 1.3 0.7 1.6 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 254.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: AB_2678081, HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 26.2 3.9 24.2 18.4 3.6 6.1 7.7 5.2 9.2 7.7 4.9 1.9 33.5 8.1 15.1 6.7 7.9 13.4 2.8 30.9 3.5 20.4 4.3 5.2 1.2 24.4 7.6 3.9 3.1 6.8 30.6 9.8 10.0 6.6 20.7 15.3 9.2 3.8 4.7 16.1 8.7 14.6 12.8 21.2 6.8 10.0 7.1 5.2 3.9 9.0 26.6 16.8 11.8 10.8 15.7 8.6 13.2 9.7 13.5 5.0 6.1 7.5 11.4 8.4 10.9 9.5 1.8 20.0 19.7 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 26.8 11.5 11.8 34.8 91.7 8.4 11.6 22.9 1.4 7.9 17.4 7.9 61.2 28.2 16.0 101.0 18.1 20.6 23.3 16.2 34.6 26.7 52.4 0.0 22.9 49.6 15.9 47.1 16.0 32.6 19.5 13.8 30.5 45.5 5.4 34.9 106.1 27.9 25.8 21.5 23.0 12.2 45.3 22.1 72.3 36.2 254.8 40.5 18.1 24.3 54.7 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 0.0 0.0 0.0 0.0 0.0 18.0 8.4 38.2 0.0 0.0 1.8 0.0 0.0 3.3 5.4 21.0 0.3 0.0 0.0 5.4 0.0 0.0 3.6 0.0 0.0 0.1 7.9 4.7 0.0 0.0 23.3 1.4 0.0 0.0 0.0 0.0 39.5 3.5 0.0 0.0 0.3 2.6 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.0 0.1 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: AB_2683500" "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavorable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 3.4 4.5 16.2 4.5 5.1 5.1 7.0 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 4.0 7.1 14.7 13.2 7.5 3.8 4.6 16.0 11.6 12.2 2.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.3 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 17.9 15.6 38.9 16.7 24.6 21.6 11.4 5.1 18.7 22.7 19.2 74.6 53.4 16.6 8.9 23.5 21.8 10.0 0.0 10.3 41.1 27.2 25.6 18.5 5.9 27.7 27.0 15.5 27.6 71.2 42.2 17.5 46.5 25.3 36.9 9.1 34.4 12.8 10.5 10.3 11.2 35.2 6.5 17.9 29.3 19.0 23.2 53.9 38.8 11.3 37.6 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 8.6 10.2 3.7 8.1 10.0 6.8 6.5 8.2 4.6 6.0 11.0 12.8 9.1 3.6 12.6 7.0 4.7 12.2 5.4 13.5 8.5 6.9 17.6 5.0 7.5 11.0 5.5 2.7 3.7 5.3 9.0 7.7 11.7 3.0 5.8 6.4 3.0 4.5 7.0 17.7 3.0 10.8 5.2 28.1 4.4 5.0 9.9 6.3 20.0 10.5 2.0 4.4 10.2 9.1 8.8 31.4 6.1 5.7 2.9 5.0 3.5 15.1 9.3 2.5 3.8 6.7 7.9 10.3 7.5 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 14.9 14.9 16.4 24.6 14.4 20.5 12.2 25.5 28.1 14.8 27.9 29.5 44.8 14.9 40.1 48.5 21.9 30.7 23.3 34.3 26.4 19.3 22.8 8.1 16.3 25.9 17.5 6.9 28.8 12.3 16.2 20.8 11.7 18.6 19.8 19.0 29.9 27.5 22.4 32.9 21.4 35.7 6.5 16.9 44.2 20.3 16.3 43.1 16.6 21.2 17.9 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 44.4;Spermatocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: AB_2676570, HPA049033: AB_2680608" "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favorable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.4 6.4 13.5 11.8 4.2 7.8 10.5 21.9 9.5 16.8 19.1 18.0 7.5 14.9 5.7 10.9 12.7 8.2 18.2 7.8 18.5 14.9 15.7 27.9 14.1 16.3 3.1 14.8 6.8 5.5 2.5 19.0 4.6 5.0 10.7 7.8 26.6 26.0 14.4 5.6 13.5 5.3 14.0 13.1 7.9 12.1 27.9 15.9 7.5 7.4 14.7 6.1 32.9 10.5 9.6 7.0 13.8 7.5 6.2 16.0 11.2 11.7 15.4 23.6 23.2 24.5 8.9 19.8 18.0 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 3.0 3.4 0.8 7.7 7.2 3.5 3.4 7.6 0.0 1.2 3.5 9.8 8.0 1.7 3.0 44.4 4.5 2.7 0.0 4.0 22.1 6.4 4.6 8.1 5.5 7.6 6.4 1.2 8.6 2.7 16.6 9.5 5.1 6.8 3.6 3.8 2.4 3.7 2.9 13.1 4.2 2.7 0.0 8.1 53.1 21.1 8.5 13.8 5.7 5.1 8.1 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 271.8;Hofbauer cells: 287.3;Pancreatic endocrine cells: 255.4;Proximal tubular cells: 236.7;Syncytiotrophoblasts: 278.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 43.9 36.0 33.0 23.9 25.3 33.1 23.7 43.7 35.7 42.9 44.1 32.0 38.4 22.4 35.4 38.7 58.0 31.5 36.4 43.6 56.8 25.8 30.2 39.0 38.5 50.6 33.0 25.0 29.3 33.4 35.0 38.8 50.2 31.9 39.8 38.8 34.4 30.1 56.3 32.5 64.3 44.9 30.0 72.1 58.4 23.5 20.8 21.3 46.8 38.6 31.2 29.6 18.3 99.9 40.8 35.8 36.8 27.0 30.4 31.2 35.3 34.1 43.7 34.2 41.8 41.3 37.5 27.4 37.8 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 62.5 90.6 0.0 0.0 0.0 0.0 0.0 0.0 116.4 91.0 113.4 0.0 190.4 225.5 210.9 0.0 0.0 0.0 0.0 197.5 271.8 0.0 0.0 64.0 0.0 287.3 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 196.6 0.0 0.0 255.4 0.0 0.0 236.7 0.0 0.0 0.0 0.0 0.0 0.0 278.0 0.0 0.0 0.0 EPB41L2 4.1-G ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 170000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 50.2 16.5 29.6 17.3 42.8 3.9 21.1 6.5 40.1 20.5 23.1 32.3 7.2 12.3 23.0 13.7 13.2 25.6 18.0 22.8 33.4 24.6 11.5 12.1 24.4 15.4 50.5 33.1 44.4 9.1 8.2 8.4 26.2 34.8 11.2 23.2 52.0 10.1 15.8 16.0 7.1 21.4 20.6 59.5 25.3 11.7 32.2 51.9 6.8 15.2 14.6 11.6 15.2 16.6 10.5 8.6 0.5 8.8 1.0 2.5 1.3 8.3 8.8 20.0 27.4 13.9 22.3 6.1 14.2 18.0 14.5 20.3 16.8 11.9 10.2 26.7 19.5 11.8 4.3 7.6 13.1 29.0 43.3 17.7 18.3 10.5 9.6 8.2 0.0 22.3 10.9 0.2 25.6 9.9 23.5 22.3 15.6 49.5 29.3 9.2 2.1 14.3 3.1 18.5 35.8 9.6 22.3 24.0 0.9 24.4 8.0 2.1 0.0 5.9 0.1 11.5 21.4 3.0 19.1 27.0 17.1 32.3 28.9 42.7 24.3 0.4 9.5 11.7 0.1 26.0 0.1 3.1 0.5 1.0 8.8 0.9 2.9 1.0 1.2 8.6 10.5 1.7 0.7 0.0 1.0 3.3 2.3 2.5 1.3 29.6 42.8 6.5 39.6 33.4 24.6 50.5 33.1 34.8 51.9 6.0 11.8 15.4 12.1 13.7 52.8 12.6 22.9 20.1 28.4 1.8 212.1 2.8 0.0 28.2 273.7 47.2 31.6 0.0 14.3 5.1 74.8 3.3 42.8 3.4 29.8 27.0 9.8 39.3 104.6 245.3 67.6 61.1 10.1 17.2 36.8 499.6 37.8 21.0 43.5 9.8 1331.8 116.4 56.7 54.3 79.8 8.9 2.1 5.0 21.6 6.8 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "Fanconi anemia core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 33.1 18.8 15.4 14.3 12.1 15.2 20.5 15.4 16.4 17.8 19.1 13.8 19.1 14.6 17.8 17.7 20.3 12.6 14.2 17.0 15.4 14.8 27.7 20.9 15.0 22.5 14.9 10.3 16.9 17.2 8.0 26.4 11.7 13.3 21.8 7.3 20.9 21.4 23.9 27.3 28.1 14.9 15.0 14.3 24.4 30.5 20.2 11.5 35.1 30.5 11.4 16.5 17.1 19.3 13.2 22.0 31.0 8.7 5.1 12.6 5.6 10.4 1.6 2.3 2.8 1.4 1.9 13.8 11.8 4.4 3.9 5.1 2.5 6.9 12.2 17.5 1.8 3.5 5.1 1.6 1.7 1.9 26.0 24.0 10.1 2.7 5.3 5.4 7.0 9.8 3.3 3.9 2.3 2.5 2.4 4.7 9.7 13.9 2.9 2.6 4.3 10.2 21.9 8.2 2.0 21.9 13.7 7.2 11.4 1.8 1.6 18.9 25.3 7.7 3.3 20.2 2.2 3.3 2.9 9.9 6.0 14.3 7.4 6.7 27.5 14.6 17.8 11.2 4.4 2.5 3.6 8.7 31.0 10.1 8.1 10.0 13.2 9.2 10.9 8.8 13.1 12.6 10.4 11.2 5.1 7.5 22.0 7.8 5.6 15.4 12.1 15.4 14.1 15.4 14.8 14.9 10.3 13.3 11.5 6.0 11.0 59.7 76.1 0.0 25.1 17.1 50.9 14.7 12.5 92.5 3.9 105.4 144.2 110.3 81.6 33.1 20.8 23.3 96.1 118.9 7.2 104.6 7.0 78.0 115.2 14.3 42.1 73.1 106.0 249.7 79.7 47.3 0.0 185.8 72.9 43.5 131.8 46.3 77.8 221.5 25.4 64.7 14.6 118.4 32.4 0.0 75.1 55.3 55.7 99.4 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.6" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" Nucleoli "HPA038108: AB_2675837, HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favorable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.6 7.3 32.6 13.5 9.2 5.8 7.0 2.3 2.1 3.1 5.8 0.1 2.3 4.1 3.6 1.5 8.2 4.1 5.2 0.3 5.7 4.1 5.2 0.4 9.6 3.4 0.5 12.9 3.4 5.8 2.1 10.1 3.9 1.4 10.6 0.4 4.9 0.1 0.3 1.5 6.9 0.4 3.9 5.6 9.5 2.2 4.2 12.2 14.2 3.8 1.4 4.5 5.4 5.8 3.1 0.1 1.4 6.5 3.6 3.1 3.3 2.0 1.1 0.0 9.6 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 11.9 27.5 3.7 19.8 9.0 19.2 22.7 22.9 81.7 46.6 10.4 33.4 57.4 24.9 8.6 2.3 12.5 34.9 0.0 14.6 29.6 23.6 13.3 1.1 111.2 17.5 0.0 4.7 8.0 29.1 2.4 41.7 12.6 18.6 4.6 37.9 26.9 31.2 63.3 31.5 34.7 10.7 0.0 24.2 4.8 6.1 6.8 233.8 6.4 14.6 16.6 FBLIM1 "CAL, FBLP-1, migfilin" ENSG00000162458 "Filamin binding LIM protein 1" Q8WUP2 1 15756607-15786594 "Predicted intracellular proteins" "Cell adhesion, Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 180.0;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 54.1;TIME: 84.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025287, HPA072750" Approved Enhanced "Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "Nucleoli fibrillar center" "HPA025287: AB_1848443, HPA072750: AB_2686554" "unprognostic (4.10e-2)" "prognostic unfavorable (4.07e-4)" "unprognostic (2.26e-1)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.33e-2)" "unprognostic (8.77e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (2.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.33e-2)" "unprognostic (3.01e-1)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 11.6 6.0 1.7 12.8 1.4 0.0 10.1 0.8 1.3 21.5 36.6 1.4 26.8 24.6 30.3 15.8 17.8 16.5 60.2 21.7 1.2 1.0 18.2 3.0 14.7 16.1 1.8 1.6 36.0 13.0 13.9 3.8 21.5 2.3 26.7 15.7 9.0 13.0 26.5 4.1 6.2 62.8 18.7 1.3 22.7 18.9 22.3 0.9 1.3 10.3 7.4 6.3 24.7 16.9 1.8 1.3 4.6 1.2 1.6 1.2 0.3 6.5 3.7 3.3 0.1 0.8 1.7 4.5 11.2 17.9 8.3 6.7 1.2 9.9 0.0 24.3 18.0 14.4 12.7 2.4 25.7 4.1 0.0 1.2 0.0 0.9 6.3 21.6 0.0 0.1 8.5 17.2 6.9 16.5 17.2 54.1 0.4 0.2 1.6 2.8 0.1 0.1 0.1 3.4 10.3 4.8 0.0 0.0 0.2 10.4 4.5 0.0 8.0 5.9 0.7 1.3 7.2 1.4 0.1 84.4 11.0 1.5 0.1 5.1 0.1 0.2 0.1 1.6 0.0 0.1 4.6 1.2 1.0 0.7 0.5 0.6 1.0 0.7 0.7 0.4 1.8 1.1 1.2 3.5 1.6 0.7 1.3 0.4 0.3 1.7 1.4 0.8 1.3 1.2 1.0 1.8 1.6 2.3 0.9 11.9 21.5 5.2 54.8 76.6 3.5 30.9 45.9 12.0 29.6 15.7 5.9 5.8 0.0 80.2 2.4 18.4 138.3 0.0 46.9 102.1 26.9 24.2 17.4 1.8 5.3 1.6 44.1 38.1 0.6 1.8 74.2 10.4 13.5 3.6 47.1 10.0 88.8 84.2 180.0 1.2 5.1 142.3 66.2 2.3 1.8 54.8 16.2 6.1 40.4 47.2 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 191.1;Club cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.2 58.9 0.0 0.0 19.8 0.1 0.0 0.0 0.0 15.4 0.3 0.0 4.2 0.9 0.0 17.8 19.1 4.0 0.0 0.0 4.1 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.9 2.7 0.0 0.0 0.0 2.3 5.7 5.0 0.1 0.1 0.1 10.8 0.0 11.5 15.8 0.0 0.0 0.1 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 17.9 31.8 0.0 29.5 35.6 0.0 2.7 191.1 18.7 52.4 34.9 0.0 12.6 0.0 4.0 2.9 0.5 2.6 0.0 0.2 2.7 17.5 9.8 0.0 4.3 2.0 0.0 2.4 3.1 0.3 6.5 1.1 1.3 5.0 1.0 32.0 1.6 0.6 1.4 5.6 11.5 0.1 0.0 2.1 0.9 7.7 24.2 3.3 1.5 3.0 27.7 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 15.6 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.5 3.1 0.0 0.5 0.3 0.0 4.4 0.0 4.6 0.1 0.0 1.0 0.0 0.2 0.1 1.3 0.0 0.0 2.7 29.4 0.0 5.5 0.0 0.0 0.1 0.0 0.1 3.0 0.2 1.9 0.0 5.1 3.4 0.0 0.0 0.1 0.0 9.9 1.9 0.3 3.2 0.0 0.0 4.9 9.2 0.2 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 202.5 116.8 0.0 129.3 7.7 13.3 0.9 17.8 22.7 126.3 21.0 5.9 0.3 11.6 18.8 0.0 1.6 2.0 0.0 13.0 0.0 5.4 11.3 4.7 7.8 0.2 6.4 10.9 1.8 0.0 0.2 3.4 0.9 5.0 2.8 1.0 0.5 9.4 2.9 0.4 41.7 2.9 0.0 0.1 0.0 0.0 14.4 0.0 0.5 1.5 9.0 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 31.7;Ito cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 270000000 "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.5 0.3 2.8 0.1 0.2 0.1 12.5 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 0.3 8.1 10.0 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.2 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 2.7 11.9 0.2 12.6 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 0.0 1.7 0.9 0.2 0.8 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.2 9.2 0.0 0.0 0.0 31.7 0.6 0.2 2.3 0.4 1.1 0.0 0.0 65.1 5.7 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 4.3 1.0 0.8 0.7 0.0 0.1 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.6 25.9 14.9 8.5 3.3 2.9 0.3 21.5 13.1 25.8 18.6 20.0 4.4 0.0 6.8 5.3 7.8 3.6 1.7 1.8 6.2 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 15.2 1.1 2.7 1.6 0.2 6.5 4.0 3.4 2.0 16.3 0.0 4.8 9.9 4.5 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 9.7 8.3 3.6 0.4 13.9 12.4 2.6 12.6 0.6 0.4 1.9 2.6 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 17.9 0.0 0.0 0.2 0.6 0.0 1.7 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.3 0.4 0.6 0.0 0.0 1.6 0.4 5.1 0.1 0.0 0.0 4.5 0.0 1.2 1.3 11.1 0.0 21.6 4.2 0.0 2.8 0.0 6.4 0.5 0.0 17.0 0.1 0.2 0.0 1.0 0.3 0.9 0.4 1.9 0.0 0.0 0.0 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 262.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 66.0 30.7 9.4 14.7 8.7 8.8 7.4 24.8 12.6 20.5 18.6 16.4 25.1 0.9 46.8 17.5 13.7 38.0 8.0 20.8 7.0 6.8 14.4 12.9 21.0 16.0 26.8 1.3 16.0 10.1 20.8 12.4 10.9 12.2 13.8 9.8 6.0 11.4 10.4 49.3 4.2 2.6 10.2 37.0 30.8 4.4 7.9 8.8 25.2 57.9 8.8 9.8 13.9 34.3 31.8 5.1 21.5 7.2 23.8 29.0 16.0 40.4 26.5 10.7 13.6 3.3 24.3 10.5 30.4 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 26.8 14.6 11.5 47.9 101.2 65.6 12.9 17.8 4.0 15.9 78.5 33.4 29.4 44.7 162.1 0.8 27.0 262.4 0.0 146.8 55.5 40.6 96.5 10.3 16.4 46.4 71.5 41.3 19.0 9.5 1.9 19.0 13.8 55.6 37.9 62.6 60.8 195.2 130.6 23.7 38.4 38.1 19.4 38.2 7.4 20.6 148.3 21.5 13.8 65.5 154.2 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 6.6 29.3 0.0 16.0 9.9 0.0 21.9 44.6 7.4 18.1 0.1 0.0 0.0 2.4 8.5 6.3 2.8 0.7 13.4 24.1 0.0 8.0 0.3 2.7 0.0 20.0 0.0 0.0 26.4 14.5 27.1 9.8 73.4 56.2 0.0 0.0 0.6 1.4 1.2 0.0 11.7 57.2 0.0 7.3 0.0 0.0 0.5 29.6 3.2 0.0 0.4 0.0 0.0 0.0 74.9 2.3 0.0 41.3 22.8 6.3 19.2 14.1 0.0 0.0 0.0 55.7 0.0 3.2 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 232.3 73.8 0.0 121.0 208.6 0.2 174.1 0.0 5.3 14.8 1.8 2.0 46.7 0.0 69.9 0.3 111.0 0.0 0.0 3.5 8.1 139.5 19.9 8.1 0.0 7.5 0.0 0.0 22.7 0.3 1.1 2.3 2.8 42.2 1.0 0.0 0.1 17.0 0.0 3.9 0.0 0.2 0.0 27.8 0.3 0.1 330.6 16.7 0.0 0.0 45.0 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080880-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604" Approved Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499" "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 8.8 8.0 11.0 10.0 12.2 6.9 9.8 21.2 15.7 9.7 9.9 13.8 8.3 11.0 13.0 9.6 9.1 8.9 8.2 7.8 11.1 7.9 9.6 7.3 7.1 9.4 10.5 7.1 15.9 8.8 13.5 11.8 12.9 10.3 10.1 9.7 8.6 9.6 10.8 10.3 11.4 10.6 9.7 7.5 9.6 10.2 8.9 11.1 13.6 10.0 5.6 13.1 10.3 11.4 6.5 5.7 17.4 6.4 3.0 9.7 4.4 7.4 15.8 7.5 7.9 5.0 5.7 6.2 6.8 4.8 10.5 8.8 11.2 7.0 10.6 8.8 5.4 4.9 6.6 9.4 5.6 9.1 18.3 5.8 10.0 5.9 8.2 6.5 17.3 6.7 4.9 6.6 7.1 6.5 5.0 5.8 8.4 10.5 6.7 5.1 9.6 9.9 5.7 5.2 9.9 6.7 10.1 9.5 4.7 4.8 4.6 8.3 5.6 10.8 6.8 3.8 6.8 5.6 12.5 6.5 9.1 6.8 5.0 9.7 5.7 9.2 9.2 5.7 8.8 8.3 17.4 6.0 6.5 6.1 6.4 4.2 6.2 5.7 7.6 5.7 6.5 9.7 6.1 4.4 3.0 3.3 5.0 8.4 4.4 11.0 12.2 21.2 15.7 11.1 7.9 10.5 7.1 10.3 11.1 8.9 6.4 5.7 4.7 5.5 9.4 8.5 2.5 5.3 11.4 7.0 13.7 9.0 13.3 6.2 2.0 4.5 8.1 0.0 3.9 4.6 5.2 3.1 16.1 4.5 3.5 3.2 4.1 8.6 8.2 1.5 9.5 4.8 8.5 5.4 6.5 7.4 6.6 5.7 7.8 4.8 11.2 0.0 4.9 14.4 11.6 3.1 4.6 7.4 5.6 2.6 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.5 16.7 34.7 24.4 19.6 24.5 25.1 16.3 18.3 18.7 21.7 13.8 22.9 15.1 13.4 15.2 23.5 22.3 17.3 24.4 17.5 17.8 15.2 17.3 51.7 29.6 15.9 16.4 16.9 23.2 35.6 25.4 21.0 24.9 25.9 49.1 12.9 19.0 21.7 19.0 35.0 22.5 26.6 16.7 31.0 14.7 11.5 16.5 25.4 41.0 21.7 32.8 35.3 24.0 17.3 28.8 23.2 27.7 18.4 20.4 20.3 12.8 16.1 17.6 20.8 21.3 18.5 19.2 17.8 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 65.5 38.7 24.2 78.6 73.7 63.9 10.1 33.1 69.6 69.4 94.2 37.3 101.3 64.6 51.7 30.9 42.0 85.6 0.0 41.6 64.1 64.4 60.2 53.1 20.7 35.7 19.1 105.7 35.0 15.3 14.2 75.1 31.2 25.3 34.3 96.2 28.0 50.1 90.2 64.3 55.6 50.0 51.8 35.7 56.7 54.0 72.5 103.7 47.2 78.7 75.6 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.9;Karpas-707: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.1 4.5 5.6 3.7 12.3 12.7 3.3 4.5 14.2 11.1 11.7 1.3 11.9 3.8 2.4 6.7 9.1 5.7 3.8 8.6 7.2 50.9 2.1 10.5 2.5 8.2 12.2 6.4 8.9 13.6 7.9 6.3 16.5 9.6 8.4 4.6 2.0 53.1 4.6 4.3 12.3 7.8 1.2 5.6 3.3 16.2 2.1 16.9 8.5 9.5 2.4 3.7 6.4 5.3 9.3 2.4 4.1 5.8 6.9 3.2 3.5 3.6 3.9 15.2 12.1 3.3 6.7 6.3 5.6 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 35.7 23.2 51.9 43.4 43.6 11.8 19.6 28.1 64.3 26.1 24.4 5.9 27.6 31.5 24.5 0.1 35.9 32.5 23.3 26.4 13.4 30.4 57.1 26.5 32.6 42.8 19.1 29.4 37.4 73.6 1.3 34.5 47.6 18.6 173.1 25.9 25.5 27.3 37.4 49.8 23.7 7.8 38.8 24.7 0.2 1.1 38.9 22.3 58.6 20.9 59.3 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 146.3;skin 1: 126.1;tongue: 122.8" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 81.5;OE19: 288.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 61000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: AB_2674124" "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favorable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 12.5 2.6 2.8 9.5 4.5 3.3 13.0 6.5 3.7 34.5 17.9 8.7 12.3 15.6 12.2 9.6 146.3 13.0 19.0 34.5 3.3 1.6 31.6 11.7 13.2 4.0 5.3 2.2 12.5 12.8 3.6 5.8 42.4 4.0 14.0 8.8 8.3 34.3 14.3 17.6 126.1 36.1 4.3 3.2 4.5 15.4 3.6 4.6 10.8 27.9 122.8 84.8 12.5 55.4 7.9 7.8 14.8 20.6 0.3 0.1 2.9 19.5 16.2 1.6 1.4 0.0 0.0 25.4 1.1 6.7 0.4 0.4 24.6 21.7 0.3 12.1 0.7 0.5 81.5 2.3 18.1 0.0 0.0 5.8 0.8 12.9 5.4 2.7 0.5 8.7 0.0 41.2 0.0 3.3 4.9 7.2 0.5 7.2 7.1 0.0 25.1 0.1 7.0 3.2 288.5 2.7 22.9 0.0 14.6 12.6 50.1 4.0 2.9 2.5 49.5 0.1 7.9 41.3 0.5 11.4 0.0 1.1 0.5 0.3 0.6 2.2 0.3 0.1 0.9 0.1 1.7 7.6 14.8 0.0 12.8 0.0 7.9 0.0 0.1 7.8 7.4 0.1 0.1 0.3 0.3 20.6 2.5 0.0 2.9 2.8 4.5 6.5 3.7 3.3 1.6 5.3 2.2 4.0 4.6 56.6 33.7 8.4 158.6 174.9 1.1 80.3 53.5 18.7 43.3 125.6 3.9 81.5 23.2 189.4 28.7 23.2 158.5 0.0 119.3 141.0 19.6 196.2 10.5 29.3 12.8 0.0 64.1 28.3 5.6 6.4 4.6 9.8 11.8 6.4 91.0 16.2 237.1 128.7 0.0 33.8 4.3 6.5 14.0 2.1 4.2 335.0 155.3 5.1 94.4 236.4 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Cell line enhanced" "Detected in some" "A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" NA NA "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: AB_2685972" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 6.6 12.5 0.0 0.5 0.0 0.0 11.8 0.0 16.2 0.0 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 21.3 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 7.9 0.0 0.0 0.9 20.5 0.1 0.0 0.0 1.9 2.9 6.3 8.2 0.0 0.1 13.9 0.0 1.5 9.0 0.2 0.1 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 11.9 9.1 0.5 10.7 0.0 0.4 0.3 12.7 9.4 4.5 14.0 0.0 28.2 21.6 24.5 0.3 0.1 17.1 0.0 20.6 20.1 0.8 11.8 0.0 2.9 2.4 0.0 7.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 14.1 1.0 18.2 22.9 0.0 7.3 2.1 0.0 0.2 5.8 7.0 0.0 24.8 1.5 17.2 16.2 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741885-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 90.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favorable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 3.7 39.4 12.1 8.6 8.7 0.7 14.1 1.6 15.8 8.7 25.9 2.7 27.8 28.1 5.4 8.7 33.8 13.5 28.8 2.3 6.4 4.5 23.1 5.9 13.4 0.8 2.4 6.6 18.0 32.8 21.7 4.8 19.3 7.3 18.5 17.4 10.0 36.9 44.6 1.8 33.4 36.0 6.8 1.6 1.1 25.5 2.9 3.0 3.1 19.2 17.9 20.3 15.0 22.3 0.0 2.1 0.0 1.0 0.0 0.4 0.2 19.4 10.2 1.6 2.8 0.7 1.5 7.6 2.4 4.7 2.8 2.7 11.1 38.4 0.0 10.1 3.5 8.2 29.0 3.1 20.6 1.4 0.0 4.1 4.0 14.5 9.0 1.2 0.0 10.4 0.5 32.0 7.3 8.8 12.5 5.7 0.8 5.8 0.1 1.3 16.1 0.1 0.1 3.4 16.8 6.4 2.6 2.1 4.9 26.5 35.5 1.4 1.4 15.0 21.6 2.9 10.9 23.0 1.3 5.3 4.6 12.6 4.2 5.1 0.2 0.1 0.1 4.7 0.7 5.3 0.0 0.6 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 12.1 8.7 1.6 15.8 6.4 4.5 2.4 6.6 7.3 3.0 11.9 49.9 0.5 31.7 65.7 0.5 3.3 76.5 20.1 23.9 26.2 2.0 12.1 8.3 38.3 3.6 6.7 90.1 0.0 57.6 3.7 5.6 56.0 26.6 8.6 2.5 0.0 27.9 1.3 0.3 3.6 8.1 2.5 6.8 3.6 55.5 0.8 52.7 49.1 4.6 12.5 0.0 6.5 5.0 1.8 2.5 72.6 6.6 1.9 54.5 60.9 MACF1 "ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF" ENSG00000127603 "Microtubule-actin crosslinking factor 1" Q9UPN3 1 39081316-39487177 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" Actin-binding "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 734.3;Rod photoreceptor cells: 425.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013713, HPA068064, HPA068103" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Plasma membrane, Cell Junctions, Actin filaments" "HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953" "unprognostic (2.71e-1)" "unprognostic (3.14e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (9.00e-2)" "unprognostic (6.19e-3)" "unprognostic (1.32e-1)" "unprognostic (7.40e-3)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.34e-1)" "unprognostic (3.98e-1)" "prognostic favorable (2.77e-5)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (8.57e-2)" "unprognostic (4.22e-2)" 24.1 22.6 41.4 21.4 44.0 21.2 25.2 62.6 54.0 37.1 42.2 35.3 22.7 11.9 66.5 33.6 20.3 28.0 31.5 39.0 35.9 32.7 27.2 24.4 53.5 21.2 41.1 28.6 41.5 25.0 46.2 37.1 22.8 40.5 26.3 18.2 23.3 26.0 32.0 40.8 59.2 18.4 56.7 37.0 29.7 22.9 17.7 39.0 13.3 34.5 17.9 16.0 28.0 34.8 4.8 2.6 4.9 2.8 6.4 13.7 2.0 12.6 15.4 19.0 8.6 16.8 17.4 8.2 17.4 23.6 10.8 10.8 9.2 15.3 6.6 18.4 24.7 18.1 8.4 3.4 12.5 15.1 12.7 9.4 11.7 11.5 14.9 19.2 10.8 5.0 11.8 12.9 29.9 16.1 24.8 38.2 23.1 17.2 9.0 42.4 4.2 6.1 14.1 26.2 5.3 9.1 11.5 29.1 1.2 56.4 13.7 10.5 10.7 6.9 4.7 16.6 23.9 2.0 10.7 43.0 17.7 14.2 8.4 30.4 5.4 5.2 7.9 29.0 10.3 16.2 4.9 1.5 3.8 13.7 2.7 6.7 2.3 6.8 8.6 1.9 4.8 5.4 6.8 1.3 6.4 2.8 2.6 2.9 2.0 41.4 44.0 62.6 54.0 35.9 32.7 41.1 28.6 40.5 39.0 140.0 115.4 34.3 51.5 137.1 376.9 222.7 76.5 60.2 85.3 76.8 734.3 41.1 0.0 105.2 8.2 146.8 21.9 0.0 98.3 49.9 58.2 60.0 73.1 41.2 44.1 111.2 34.7 127.1 56.4 6.8 40.6 41.9 67.4 45.1 23.8 104.0 136.1 16.9 105.7 7.9 425.5 103.5 69.7 34.4 25.0 167.4 58.5 78.3 17.8 61.3 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 85.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.2 0.0 1.3 0.0 0.0 5.4 0.1 0.2 0.0 1.1 1.6 0.0 14.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.3 2.7 0.0 0.0 13.9 0.0 0.0 2.0 1.2 1.1 0.0 3.0 0.4 0.9 1.3 4.0 4.0 0.0 2.8 0.0 0.2 12.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 0.0 8.3 0.0 0.2 0.3 0.0 0.8 0.0 85.6 13.6 0.0 0.0 0.0 0.0 0.6 12.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.3 0.1 0.0 0.1 0.0 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 31.0 22.1 31.0 21.4 15.7 19.3 18.2 28.8 31.6 36.7 38.0 28.8 25.5 36.2 13.3 23.0 16.7 29.0 37.0 29.0 43.0 26.5 27.3 18.6 17.6 22.0 24.4 34.3 45.0 15.8 16.4 33.2 43.8 20.2 25.1 23.7 17.1 27.3 24.0 23.0 43.0 20.7 15.6 23.1 16.0 27.2 60.0 18.4 15.7 21.4 13.4 17.2 21.0 17.5 24.0 24.3 11.9 24.5 19.4 18.1 17.8 18.3 34.3 19.7 21.9 40.1 21.6 23.1 11.1 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 14.9 13.9 20.1 27.2 38.0 10.0 16.2 12.7 10.7 18.2 19.2 3.9 30.7 11.6 9.6 3.3 32.4 15.1 0.0 11.5 42.5 26.3 18.7 17.4 23.1 33.4 30.2 10.4 30.1 35.7 4.9 27.9 31.3 21.9 8.2 18.5 16.9 12.8 7.0 21.2 17.5 17.1 19.4 29.9 27.6 61.5 37.4 33.2 27.4 26.9 24.5 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Cell type enriched" "Detected in single" 16 "Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "Daudi: 50.9;U-266/70: 51.2;U-698: 67.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 50.9 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.5 0.1 51.2 4.7 67.3 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MICALL1 "KIAA1668, MICAL-L1, MIRAB13" ENSG00000100139 "MICAL like 1" Q8N3F8 22 37905657-37942822 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 26.6;Syncytiotrophoblasts: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043480, HPA051956" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions, Centriolar satellite, Cytosol" "HPA043480: AB_10793950, HPA051956: AB_2681671" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (4.94e-2)" "unprognostic (4.90e-1)" "unprognostic (1.57e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.08e-6)" "unprognostic (3.46e-2)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-3)" "unprognostic (6.61e-2)" "unprognostic (8.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" 8.0 4.8 5.3 10.1 10.3 6.3 12.6 5.9 7.3 19.1 25.2 21.4 17.6 6.1 21.3 11.0 32.3 11.1 14.4 6.0 7.5 5.5 6.4 5.7 11.8 9.2 17.4 5.1 6.8 14.2 19.2 4.3 29.6 12.5 15.3 7.5 8.7 13.4 25.2 8.5 24.4 9.2 43.5 18.7 5.9 28.5 7.4 11.1 5.3 9.4 15.5 13.5 21.4 17.5 2.8 3.3 2.3 1.6 4.1 2.6 1.6 10.9 6.1 6.6 7.1 6.7 5.7 26.5 15.6 8.9 15.3 11.5 8.3 5.9 4.7 4.8 10.3 10.8 28.5 5.1 30.4 11.1 8.1 13.4 1.9 6.5 8.2 10.9 5.4 5.5 4.8 47.6 18.2 37.9 5.6 10.5 1.8 3.4 4.6 13.3 5.2 1.3 2.4 2.3 6.4 4.6 7.3 12.6 2.6 4.0 30.4 4.6 8.2 9.7 8.5 8.3 8.5 5.1 5.2 14.5 25.6 21.2 17.0 12.7 4.7 1.6 3.0 23.3 2.5 12.4 0.4 1.1 0.6 1.8 1.6 2.3 2.5 1.4 2.2 1.7 2.8 2.6 1.3 2.3 4.1 0.6 3.3 0.9 1.6 5.3 10.3 5.9 7.3 7.5 5.5 17.4 5.1 12.5 11.1 0.0 5.6 1.5 8.1 6.6 0.9 9.0 7.6 5.3 9.1 5.2 0.0 26.6 1.7 8.5 12.7 6.0 4.2 0.0 8.9 24.3 3.8 4.6 1.1 3.9 7.9 4.8 3.4 4.3 1.8 17.7 1.7 3.7 1.7 9.0 3.4 0.8 10.8 2.6 3.9 2.2 0.6 0.0 4.2 2.8 2.1 8.0 33.0 2.5 3.3 12.7 MLKL FLJ34389 ENSG00000168404 "Mixed lineage kinase domain like pseudokinase" Q8NB16 16 74671855-74700960 "Enzymes, Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 50.4" "Cell type enhanced" "Detected in many" 6 "granulocytes: 27.8;Macrophages: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078638 Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane" "Cell Junctions, Cytosol" "HPA078638: " "unprognostic (7.53e-2)" "unprognostic (1.74e-2)" "unprognostic (2.57e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.07e-1)" "unprognostic (5.69e-2)" "unprognostic (3.67e-3)" "unprognostic (1.90e-1)" "unprognostic (6.64e-3)" "unprognostic (1.37e-1)" "unprognostic (2.74e-1)" "unprognostic (1.60e-3)" "unprognostic (5.30e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.53e-3)" 18.5 4.7 5.2 15.1 8.9 21.6 13.2 2.9 7.9 6.4 8.0 3.2 5.3 8.5 7.5 3.8 11.5 5.2 9.1 6.8 6.4 3.5 7.4 6.7 17.3 14.8 10.5 1.8 2.8 8.2 1.6 3.0 7.1 8.1 6.3 9.2 6.5 12.6 4.3 2.3 3.6 10.0 6.0 11.2 26.2 8.2 1.9 8.4 4.3 6.5 4.9 10.4 9.2 50.4 4.2 9.2 25.2 17.7 1.7 8.1 7.1 6.5 12.2 0.1 0.1 3.2 6.7 0.1 8.5 7.4 8.0 11.9 7.0 13.2 0.1 9.8 7.2 6.9 10.5 2.2 12.2 3.0 4.1 0.3 9.2 9.1 8.0 2.3 6.0 9.6 4.5 1.2 8.5 3.0 4.7 19.3 10.7 1.3 1.3 6.2 10.9 3.4 12.0 1.1 14.3 15.0 6.7 0.9 11.7 11.4 4.8 0.5 0.4 6.7 4.5 3.7 0.0 3.2 6.3 21.0 4.0 2.4 3.6 5.8 5.7 19.2 1.6 7.3 21.2 1.9 8.3 17.7 21.7 5.8 10.6 7.9 4.2 6.5 6.0 9.2 2.8 3.6 5.5 25.2 1.7 10.2 0.5 8.1 7.1 5.2 8.9 2.9 7.9 6.4 3.5 10.5 1.8 8.1 8.4 3.0 15.4 8.1 4.8 3.1 0.0 1.6 2.5 2.7 7.9 1.8 0.0 0.2 1.7 4.0 2.6 17.9 5.8 0.0 4.6 0.5 3.8 2.0 27.8 0.9 14.2 1.6 1.2 14.7 15.5 3.8 0.9 24.1 6.8 1.0 5.6 0.0 4.1 9.1 0.4 0.3 0.4 0.0 3.3 0.0 0.2 2.5 0.2 10.0 6.4 5.1 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.7 8.6 21.9 11.3 8.0 14.2 5.9 8.1 10.4 9.6 28.0 10.1 18.6 15.0 7.1 4.3 8.8 8.7 18.0 1.2 14.1 39.7 12.6 20.5 18.0 16.4 19.3 17.8 11.4 12.9 12.1 15.7 8.5 11.1 25.8 18.1 12.9 5.5 30.3 18.3 25.8 16.6 6.2 19.3 19.2 8.6 32.6 7.8 4.3 27.2 13.9 9.8 22.2 15.8 3.3 13.1 18.9 7.8 12.2 13.8 9.8 8.0 14.8 8.9 20.3 6.0 17.1 10.2 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 6.0 13.6 23.8 14.5 13.1 30.3 3.0 10.2 10.7 6.8 15.7 19.6 58.4 29.9 30.2 39.4 11.9 36.0 23.3 37.0 37.8 20.1 13.3 8.1 14.5 41.0 28.6 27.6 19.6 22.1 78.3 13.8 14.5 16.9 34.3 26.7 26.0 26.7 37.4 14.2 30.7 24.7 19.4 15.5 24.7 25.4 13.6 44.1 18.7 37.1 11.1 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.8 4.7 4.8 7.8 6.0 27.1 4.2 6.3 7.1 3.8 9.9 4.4 9.2 8.5 9.0 14.6 5.8 24.8 5.0 4.6 4.7 5.2 25.6 4.7 5.3 5.1 6.2 7.6 9.1 18.0 9.5 7.7 7.1 5.5 13.4 6.0 5.0 9.1 2.7 11.2 8.4 4.6 14.2 5.7 9.5 3.6 7.1 6.8 29.1 16.4 10.6 8.3 9.3 5.6 7.6 4.6 9.4 9.0 8.6 6.1 5.5 5.7 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 20.8 5.9 4.7 3.5 4.7 93.3 23.0 10.2 6.7 4.5 31.4 145.3 2.5 1.7 3.3 243.8 10.6 5.9 0.0 5.5 3.0 3.7 5.4 24.2 8.9 7.2 35.0 27.1 10.4 14.2 250.1 5.2 5.0 15.1 4.6 9.4 9.4 5.7 7.0 2.5 6.3 92.4 12.9 3.9 25.8 9.5 4.3 5.4 5.1 8.3 5.8 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.1 12.2 1.3 9.7 4.2 4.8 1.9 5.5 6.4 2.8 4.8 0.7 10.2 7.4 16.9 7.0 4.1 10.3 3.7 3.1 0.9 9.5 4.0 9.7 4.2 6.6 6.4 3.4 5.7 5.4 13.2 3.6 7.0 5.6 5.6 9.9 0.1 4.9 2.8 10.9 5.7 8.2 6.0 5.3 6.8 11.2 1.7 2.4 6.6 5.3 1.8 6.4 8.1 4.3 3.5 2.0 14.0 10.1 6.5 5.5 4.9 4.9 2.8 1.8 1.9 2.5 0.8 10.4 3.9 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 0.0 6.4 1.7 1.6 2.3 1.2 10.8 5.1 6.7 2.3 7.0 2.0 3.0 1.7 6.0 1.5 3.0 4.2 0.0 3.4 1.7 2.5 1.8 0.0 9.6 5.7 0.0 2.4 4.3 5.3 2.7 1.1 1.9 1.7 5.4 4.1 5.6 5.1 7.0 1.1 4.3 3.2 0.0 2.1 1.9 1.9 4.1 0.5 0.5 4.5 0.9 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.1 10.1 16.1 7.6 3.7 6.7 22.9 8.0 5.8 8.0 7.5 8.9 4.6 9.9 2.9 5.3 5.1 8.7 7.9 6.2 6.1 4.3 16.8 12.0 8.2 10.6 8.5 8.0 5.2 7.7 5.1 5.5 6.8 8.9 8.5 12.4 9.1 3.9 9.3 5.4 8.7 18.6 10.9 6.6 17.8 8.4 11.3 5.9 9.0 9.4 8.3 6.6 12.8 5.5 5.9 9.3 9.6 5.1 8.0 6.5 6.4 7.9 4.5 5.7 9.3 9.5 1.6 9.4 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 32.8 12.5 7.0 12.2 7.3 39.9 16.1 10.2 22.7 1.2 10.4 17.7 12.6 3.3 10.1 14.3 14.6 8.5 0.0 8.2 10.9 11.3 8.0 9.3 10.6 8.3 23.8 6.9 12.9 10.5 3.8 40.6 10.2 13.5 10.8 10.9 14.6 14.3 11.5 28.3 6.8 50.7 6.5 9.8 54.9 23.8 6.5 6.5 10.9 10.9 17.1 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.7 0.0 0.2 0.1 0.0 0.0 4.4 0.0 0.1 0.6 0.4 14.8 2.0 0.1 2.4 0.0 0.9 23.0 3.3 4.9 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 14.1 0.2 3.3 0.2 0.0 3.9 1.1 0.2 0.0 3.2 0.0 0.3 0.4 2.7 2.0 0.2 0.1 1.8 1.1 6.0 5.4 1.3 1.9 7.8 0.2 1.3 0.9 7.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.4 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 0.0 3.4 0.0 6.8 8.8 3.9 0.0 7.6 4.0 4.5 5.2 0.0 38.8 11.6 4.0 5.9 0.0 0.0 0.0 3.7 1.2 0.6 4.0 0.0 0.0 3.5 0.0 4.7 0.0 0.3 4.5 1.7 0.3 1.7 0.0 0.8 1.4 2.7 0.0 1.8 0.0 0.0 0.0 0.1 1.6 1.5 16.7 7.6 1.3 1.9 6.8 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662778 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.8;pancreas: 31.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" No No "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: AB_2677545" "prognostic favorable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favorable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 2.7 6.1 11.7 3.5 12.4 2.1 2.8 26.8 16.1 2.0 3.0 2.2 3.7 2.0 2.4 3.6 2.7 2.5 3.1 2.3 13.8 7.2 5.5 3.1 3.5 4.0 7.9 5.7 3.3 31.0 5.3 13.9 1.5 7.4 2.7 2.0 1.4 3.8 4.6 7.0 1.5 2.5 2.7 3.7 3.7 3.2 16.9 3.4 2.5 2.3 1.4 3.4 2.9 3.1 11.4 5.3 3.7 1.0 1.2 8.5 2.1 5.5 6.0 1.7 14.8 1.2 0.2 3.1 0.1 0.7 2.2 2.1 3.0 2.3 9.4 2.8 0.1 0.8 4.4 3.4 0.7 0.5 4.4 3.2 3.8 2.8 3.4 1.6 1.5 8.9 0.1 0.3 2.1 0.8 1.4 1.1 14.1 0.3 2.2 0.4 5.5 9.6 2.0 2.0 7.7 3.9 17.4 1.1 15.2 5.9 3.2 14.3 7.7 0.9 2.1 2.3 0.5 12.9 0.6 0.9 0.2 0.5 1.4 2.9 2.3 7.3 8.4 1.7 3.4 0.6 2.1 1.0 0.4 4.5 0.5 8.5 11.4 6.4 5.9 1.2 7.4 3.2 2.4 3.7 1.2 0.1 5.3 6.1 2.1 11.7 12.4 26.8 16.1 13.8 7.2 7.9 5.7 7.4 3.4 3.0 4.3 8.1 1.4 0.8 9.7 1.0 12.7 4.0 2.3 19.2 3.9 4.6 28.2 6.6 42.8 2.7 2.1 0.0 13.1 0.2 2.4 2.1 5.7 3.8 4.0 30.2 32.6 1.3 3.2 203.1 3.4 3.1 5.0 1.0 2.4 15.2 5.2 2.6 1.4 12.9 7.6 0.0 2.1 4.6 2.6 1.4 2.4 9.6 2.9 1.4 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.2 3.9 1.3 1.7 0.7 1.9 16.3 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 10.5 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 5.9 1.6 0.0 0.1 0.7 10.9 2.0 4.6 3.0 0.6 0.0 0.0 0.0 1.0 6.7 0.0 0.0 6.7 8.7 1.0 0.0 1.4 2.7 16.9 18.1 3.3 1.1 4.9 16.0 4.2 13.8 12.7 0.2 0.1 1.0 2.4 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 80.4 49.2 0.0 0.0 0.0 0.0 0.0 0.0 49.5 71.7 54.1 0.0 2.5 5.0 30.3 0.0 0.0 0.0 0.0 23.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell type enhanced" "Detected in single" 20 "Bipolar cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" NA NA "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: AB_2686827" "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.0 16.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.8 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.5 0.4 0.0 1.0 0.0 0.1 0.0 4.5 0.0 0.0 3.7 0.8 3.2 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 2.4 6.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291024 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 648.1;Enterocytes: 781.7;Paneth cells: 737.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9" "Group enriched" "Detected in many" 6 "B-cells: 49.1;granulocytes: 39.1" "Cell line enhanced" "Detected in many" "HaCaT: 96.9;HHSteC: 94.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA 210000000 "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favorable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 60.9 6.4 2.9 32.3 3.7 2.7 69.9 3.6 3.7 30.6 78.8 3.0 24.3 27.8 30.0 35.6 48.3 28.0 38.4 107.5 3.0 2.4 19.8 49.0 78.8 91.6 6.3 2.2 23.3 20.5 11.7 6.7 53.0 16.5 34.7 34.7 12.8 34.5 27.4 150.1 26.4 96.3 27.2 8.6 52.9 28.3 14.3 3.6 23.4 76.9 54.9 41.9 65.0 38.9 49.1 6.8 39.1 0.5 1.7 3.2 9.2 34.5 22.3 1.6 0.0 8.2 5.6 36.0 10.6 33.0 27.6 45.4 47.1 53.7 0.0 3.0 28.6 14.0 96.9 11.3 61.3 28.0 0.0 17.5 34.4 6.7 76.3 94.4 0.0 1.8 16.1 32.3 14.0 50.9 29.6 49.3 3.0 7.4 8.8 6.5 6.1 0.1 0.6 3.2 16.7 18.0 29.0 1.3 12.1 14.2 32.9 6.2 2.5 11.4 10.5 0.1 38.8 8.6 15.2 43.4 10.8 2.5 0.0 0.0 4.2 0.0 11.3 11.9 0.0 5.1 0.0 0.5 39.1 2.8 0.1 0.0 49.1 0.5 3.2 6.8 44.9 0.1 2.0 1.7 1.7 0.3 0.7 0.4 9.2 2.9 3.7 3.6 3.7 3.0 2.4 6.3 2.2 16.5 3.6 71.5 92.6 110.2 648.1 325.4 6.5 205.6 201.2 180.7 158.1 48.8 27.5 481.5 13.3 337.3 7.0 238.0 781.7 23.3 152.6 92.5 136.8 121.0 11.6 70.6 44.6 1.6 97.3 328.4 20.6 5.3 4.6 29.4 38.8 5.4 406.4 7.0 203.4 737.0 0.7 62.7 43.8 310.4 177.4 0.5 42.4 173.0 97.8 33.0 340.8 482.4 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.4 0.0 0.0 1.8 0.0 5.4 9.1 2.2 1.3 0.1 0.2 0.0 0.2 4.0 0.2 0.1 0.0 13.8 0.6 0.0 0.0 6.7 0.2 0.3 10.4 0.0 0.0 5.4 0.0 3.1 0.7 0.5 24.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 39.2 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 0.0 5.6 0.0 0.0 0.8 1.3 5.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.1 26.3 0.0 23.3 0.3 0.1 5.1 0.1 1.1 0.0 0.4 0.0 1.7 34.4 1.3 1.9 41.1 0.4 5.0 0.0 1.0 0.3 0.9 0.0 33.6 0.0 0.2 25.8 14.6 0.7 1.1 1.0 0.2 0.0 0.0 0.1 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.8 0.0 0.0 0.2 0.1 0.0 12.1 0.0 0.0 0.1 0.1 0.2 42.0 0.0 0.0 0.0 0.0 22.6 0.0 13.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 18.6 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 36.7 0.0 0.3 11.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 3.0 3.4 0.0 20.8 6.0 0.2 1.4 45.9 6.7 11.4 31.4 3.9 15.3 10.0 12.0 0.4 0.0 2.6 0.0 9.6 2.3 0.8 11.1 0.0 0.0 2.0 0.0 3.5 0.0 0.0 1.1 0.3 0.0 6.8 1.0 10.5 0.0 12.7 7.0 0.7 0.0 0.9 0.0 1.0 0.7 0.0 11.2 9.4 0.0 12.4 37.6 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.4;Ito cells: 448.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Cell line enhanced" "Detected in some" "EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: AB_2685911" "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.3 0.3 0.1 6.9 0.1 0.3 3.6 0.6 0.3 0.1 0.8 0.5 0.1 0.3 0.0 0.0 0.3 2.8 0.0 9.1 28.0 0.0 1.5 0.5 0.6 0.0 0.0 0.0 1.0 1.9 0.4 0.0 0.7 0.4 5.2 0.8 0.0 0.4 0.7 0.0 1.6 0.2 0.0 0.6 40.9 0.4 0.4 0.1 2.4 0.5 0.4 0.3 0.2 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 0.0 19.9 13.7 0.8 3.3 5.4 9.2 17.8 0.0 1.2 3.5 0.0 0.0 0.0 1.4 4.3 113.4 4.3 46.7 0.8 0.0 1.9 0.6 23.3 2.0 0.3 4.8 0.0 448.7 26.3 2.5 1.1 2.0 5.0 0.0 4.8 0.3 7.2 14.4 0.0 0.0 0.8 0.0 0.9 0.7 0.5 1.4 0.0 1.7 5.2 0.6 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: AB_2682359, HPA054822: AB_2682614" "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favorable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.5 4.9 2.9 0.2 6.2 8.3 3.0 12.3 23.8 5.1 4.6 8.1 3.8 0.0 3.7 11.3 14.8 12.9 3.1 9.7 7.2 13.6 4.9 0.1 7.5 11.2 7.6 0.0 0.4 6.1 9.0 10.6 14.5 13.3 13.8 4.4 0.0 0.2 12.4 9.1 6.9 0.0 3.1 8.3 6.3 24.8 6.3 0.8 12.6 9.3 15.5 0.0 12.7 14.2 0.7 3.5 3.9 0.3 23.4 8.0 5.6 15.5 11.1 0.1 1.6 0.0 10.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 23.8 27.4 9.7 78.6 56.3 3.1 19.3 76.5 18.7 33.0 17.4 3.9 21.8 0.0 51.8 3.4 46.7 63.1 0.0 53.2 4.5 30.5 99.0 1.1 36.5 5.1 9.5 42.2 8.0 1.0 2.1 15.8 1.8 16.9 2.8 41.3 7.0 84.8 57.5 17.0 11.2 0.6 58.2 35.8 3.6 5.8 33.2 22.4 1.0 48.9 100.5 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 14.3;RT4: 27.4" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340" "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 27.4 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 0.0 0.0 0.0 0.1 0.5 11.2 2.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.1 1.7 1.5 7.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.9 11.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.3 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell type enriched" "Detected in many" 9 "Collecting duct cells: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: AB_2677598" "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 8.5 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.3 0.0 0.0 0.3 3.0 0.0 12.3 0.0 27.4 10.9 0.0 0.3 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 0.0 0.0 0.5 0.0 0.5 0.5 3.5 2.5 0.0 0.0 34.9 0.0 1.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.7 1.8 4.1 2.3 3.0 3.5 0.0 3.9 0.0 0.0 0.1 0.0 0.3 1.0 1.0 0.0 2.3 0.4 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 13.0 18.4 10.1 11.9 6.5 4.3 20.5 11.1 6.7 14.4 12.2 23.4 7.5 21.8 5.7 7.9 8.0 14.5 11.6 15.5 6.2 5.5 23.7 11.8 12.8 12.6 6.2 28.3 10.2 5.5 7.8 19.5 9.9 5.2 8.7 11.7 16.6 6.3 8.5 26.5 27.2 11.6 8.4 10.4 13.4 47.4 10.4 9.6 7.5 16.0 5.5 3.9 8.2 23.6 10.8 5.4 9.6 12.8 6.5 11.0 14.2 8.4 11.3 9.7 7.2 25.6 9.2 10.9 15.8 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 20.8 35.8 52.9 72.3 38.9 26.5 14.2 25.5 34.8 33.0 21.0 15.7 80.7 14.9 65.2 48.5 37.9 36.0 23.3 23.4 117.3 32.9 62.0 46.2 29.2 83.7 25.4 25.3 31.3 37.8 94.1 20.4 49.8 32.1 146.1 29.9 22.2 58.6 42.1 17.3 34.2 28.7 6.5 26.9 30.9 22.8 33.1 100.7 41.5 40.0 87.7 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.5 9.9 9.9 30.6 13.7 17.7 15.6 11.6 16.9 9.6 21.9 3.7 23.5 18.5 13.1 16.9 27.5 10.2 14.0 21.8 17.2 6.5 13.3 8.5 7.9 7.6 8.8 5.4 6.6 11.6 20.2 10.9 17.3 24.2 14.6 10.4 3.2 13.3 18.2 14.7 9.3 11.5 8.0 5.4 10.2 11.4 16.3 21.1 17.5 14.9 28.1 17.1 10.7 15.2 10.9 10.5 21.1 9.8 14.9 10.6 7.9 11.7 9.7 9.3 11.2 11.5 20.7 20.3 8.8 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 23.8 19.0 6.7 28.6 34.8 72.3 33.0 20.4 71.0 26.1 38.4 66.8 10.4 11.6 22.7 31.3 27.8 11.7 23.3 26.3 21.3 31.0 36.1 11.5 13.9 16.8 30.2 34.0 22.1 30.5 12.1 18.7 22.7 28.7 6.4 33.6 43.2 26.4 11.5 26.9 20.5 63.0 12.9 25.0 17.0 20.4 39.5 8.8 13.8 17.0 25.0 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.4 1.0 12.0 0.1 1.6 12.7 0.2 6.8 11.2 7.9 7.3 2.0 1.4 0.3 1.6 8.9 3.5 0.0 1.9 0.0 9.3 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.2 1.1 3.1 8.4 2.8 0.1 0.1 4.9 0.8 2.0 0.1 4.1 0.7 3.8 0.0 0.6 0.0 0.0 0.4 4.8 2.0 3.5 1.8 0.2 1.8 0.3 0.1 2.2 7.7 5.1 2.8 4.3 0.1 0.1 0.0 1.5 1.6 11.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 0.0 0.0 0.0 0.4 0.0 13.7 1.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 3.4 0.0 4.8 10.9 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.3 5.3 0.5 0.0 0.7 0.5 10.5 0.0 0.3 1.9 10.0 0.0 0.0 0.0 0.6 0.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.9 16.2 1.2 3.8 1.1 0.8 8.9 1.8 4.0 2.3 2.4 1.9 52.8 4.2 20.4 1.3 13.3 28.3 1.0 26.3 1.9 24.0 3.4 5.5 4.0 2.6 4.5 0.6 2.5 3.2 11.5 2.5 5.2 9.6 2.5 1.2 2.6 6.7 1.2 4.4 1.5 2.3 5.5 13.2 14.9 1.8 0.9 9.2 32.7 35.5 3.9 3.9 6.4 10.4 2.4 2.8 7.2 1.7 5.7 1.8 3.4 3.8 4.1 9.7 11.8 2.1 17.4 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 14.9 22.7 19.3 32.9 57.8 2.9 5.5 10.2 17.4 40.9 15.7 23.6 11.3 3.3 21.9 0.9 4.5 26.4 0.0 31.3 69.5 4.8 31.7 0.0 11.5 10.7 15.9 4.1 4.3 5.1 0.7 12.0 6.0 5.0 1.0 13.0 31.5 34.3 19.0 11.3 3.3 45.7 19.4 15.5 0.3 3.2 49.9 10.4 4.4 14.9 45.4 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786456-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 45.2;Peritubular cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RT4: 12.8;SuSa: 13.4;WM-115: 15.6" "Low region specificity" "Detected in many" HPA051646 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" No No "Plasma membrane, Cell Junctions" Cytosol "HPA051646: AB_2681562" "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 1.3 3.6 6.8 1.3 7.7 0.5 2.5 2.8 17.0 4.7 3.2 3.7 4.6 1.8 3.3 5.8 7.2 3.6 6.3 1.5 7.4 5.5 5.3 7.6 8.1 1.0 5.7 9.1 13.8 7.2 5.5 6.1 14.3 5.8 10.6 3.0 3.6 6.0 5.8 0.7 7.9 1.4 2.1 7.9 1.7 2.6 5.8 2.5 1.8 3.1 3.4 3.4 6.4 4.3 0.0 0.9 1.1 0.0 0.0 0.2 0.0 4.0 0.5 7.5 1.0 0.4 1.2 4.2 0.4 1.3 1.6 2.6 4.9 0.0 0.0 1.4 1.0 0.3 3.2 3.8 10.7 1.9 0.0 2.9 0.0 0.0 0.8 2.5 0.0 5.1 0.2 7.5 12.3 0.5 2.7 9.2 0.0 0.0 0.0 2.6 4.3 0.0 0.0 6.6 0.0 0.0 0.0 8.3 0.0 7.0 12.8 1.1 0.6 0.3 0.1 12.0 13.4 4.4 0.2 4.3 12.0 1.5 0.0 0.4 0.0 0.0 0.0 7.9 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 6.8 7.7 2.8 17.0 7.4 5.5 5.7 9.1 5.8 2.5 0.0 1.0 0.0 2.7 1.6 5.1 3.1 5.1 1.4 2.3 3.5 45.2 7.7 3.3 2.7 0.5 5.8 0.3 0.0 0.0 1.0 0.5 5.4 0.0 4.9 0.5 1.6 1.2 11.6 0.6 0.0 3.4 0.0 0.0 0.0 0.5 1.8 1.5 0.0 78.1 0.9 17.7 0.0 0.9 0.0 1.3 1.8 1.7 0.5 0.4 4.8 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.2 5.9 33.9 12.3 2.2 5.4 16.2 5.1 4.8 2.5 19.6 1.7 9.3 4.9 10.8 6.3 3.1 5.5 4.8 2.4 1.4 3.0 4.1 6.5 11.1 1.5 5.8 9.7 2.3 5.0 5.9 21.1 6.8 2.7 4.1 3.7 17.9 4.0 2.7 3.9 2.0 4.3 6.6 0.5 9.5 5.5 15.0 4.0 1.5 1.2 4.5 3.3 8.7 4.7 4.7 2.6 7.2 8.0 3.4 9.3 3.0 0.7 2.1 0.6 16.4 1.3 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 20.8 4.1 2.7 10.8 4.6 18.5 2.8 5.1 34.8 5.7 5.2 21.6 5.0 1.7 4.1 130.6 6.7 2.2 0.0 2.5 7.9 8.5 6.5 5.8 4.0 89.9 4.8 4.1 3.7 20.7 97.9 10.0 19.2 5.0 1.8 2.3 14.2 6.0 2.0 5.6 16.8 25.0 0.0 6.6 15.1 10.6 2.5 5.6 4.4 2.8 5.9 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 13 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "RT4: 8.9;SCLC-21H: 2.6" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Region enhanced" "Detected in some" "pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 151.6;Late spermatids: 248.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favorable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favorable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.7 5.3 18.3 3.0 11.2 7.6 7.2 9.8 7.3 4.9 6.4 6.4 16.0 11.5 5.5 13.2 4.6 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 8.5 6.9 8.7 11.0 8.7 3.7 12.9 10.0 13.5 1.5 11.9 5.0 7.1 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.9 13.5 4.6 5.7 12.0 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 6.0 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 11.9 7.4 4.2 8.5 8.8 1.3 2.0 12.7 58.9 7.9 12.2 3.9 8.2 1.7 14.7 151.6 3.8 27.2 0.0 17.1 16.1 6.0 12.7 0.0 3.2 8.5 0.0 8.1 4.3 6.6 248.2 8.6 10.8 8.5 11.8 21.2 2.3 13.7 24.6 8.5 7.9 5.2 12.9 2.8 36.6 10.6 16.3 14.2 4.9 13.8 13.7 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell type enriched" "Detected in some" 220 "Cardiomyocytes: 650.0" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.3 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.7 0.7 0.4 0.5 0.9 0.1 0.1 0.1 0.0 0.4 0.2 0.2 0.3 0.6 0.4 0.6 0.2 0.3 6.2 0.1 1.2 0.1 0.3 0.0 0.5 0.3 0.3 0.3 0.3 0.2 1.9 0.2 0.0 0.7 0.2 5.9 0.3 0.0 0.6 0.3 0.4 0.1 6.3 0.1 0.3 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 1.4 1.3 1.4 650.0 0.0 1.4 1.2 0.0 2.0 0.1 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.9 0.7 1.1 0.2 0.2 0.0 0.0 0.0 0.3 1.0 0.9 0.8 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.3 0.0 0.5 0.7 0.6 0.4 0.0 0.7 0.0 0.9 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 241.2;Rod photoreceptor cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "A-431: 53.3" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161" "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favorable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.3 1.7 4.3 4.8 20.1 19.7 23.3 8.1 6.0 13.0 7.1 6.5 19.5 7.7 8.1 4.5 7.0 32.9 6.9 17.1 14.8 27.3 5.0 7.4 4.6 32.9 5.7 3.0 14.1 15.3 12.3 10.1 6.1 3.7 27.2 2.1 4.5 5.2 6.8 7.5 1.1 0.4 10.4 33.4 11.7 3.9 6.1 0.8 33.4 35.6 1.9 3.3 2.9 20.8 0.6 9.9 6.7 1.6 39.0 9.7 10.5 7.5 8.3 5.4 1.1 0.1 11.2 4.3 3.6 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 41.7 21.4 1.4 65.1 57.9 241.2 34.6 50.9 9.4 5.7 3.5 33.4 24.0 0.0 27.8 2.7 42.7 67.5 0.0 20.8 23.1 14.7 83.3 5.7 92.7 4.9 17.5 11.1 25.2 17.0 3.6 27.0 2.8 27.0 4.6 41.5 123.0 32.6 42.5 13.1 1.4 273.3 0.0 10.3 21.3 11.1 56.0 36.2 3.1 36.2 146.9 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.9 9.3 16.5 6.0 16.2 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.9 15.6 20.1 12.2 24.8 15.1 18.7 25.8 32.2 11.6 13.8 28.4 22.9 28.9 43.8 17.3 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.1 18.4 26.5 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 14.9 15.6 44.9 49.0 65.3 20.7 10.9 48.4 28.1 28.4 33.2 9.8 46.3 59.7 71.4 117.2 35.8 68.3 23.3 66.2 74.0 37.9 74.7 17.3 45.7 54.3 17.5 50.6 32.5 53.2 96.3 25.0 47.0 37.1 59.5 68.9 18.9 55.2 56.1 27.6 74.5 26.2 19.4 47.6 72.3 76.8 71.8 43.1 44.7 83.1 77.4 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA016579: AB_2669392, HPA059374: AB_2683995" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.5 20.5 19.6 14.2 10.1 19.0 21.9 26.0 22.2 6.1 25.8 7.8 14.9 20.2 12.1 17.0 13.7 18.5 10.9 10.3 26.3 13.0 12.4 14.0 29.1 12.9 13.0 24.8 10.5 24.9 14.2 12.0 17.3 15.6 9.8 18.1 16.2 10.9 18.5 13.6 23.5 12.7 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.3 4.7 20.5 20.9 15.8 15.4 13.0 24.7 17.9 19.5 17.3 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 8.9 15.7 15.7 11.9 10.4 39.6 7.7 10.2 5.3 5.7 12.2 13.7 26.0 33.2 33.2 19.8 15.4 22.2 23.3 35.0 28.5 23.5 15.6 16.2 11.3 24.4 41.3 28.7 9.2 9.1 60.6 18.7 11.4 25.3 29.7 17.4 52.7 36.4 17.5 18.7 17.0 17.1 12.9 14.6 18.9 17.7 11.8 25.7 22.3 19.1 10.1 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 7.0 8.0 0.0 52.5 0.4 0.1 12.5 1.2 1.1 0.0 0.1 12.8 9.0 0.0 27.0 5.9 1.7 16.2 1.6 11.2 0.0 0.1 11.2 0.1 11.3 0.1 1.1 0.0 0.0 1.4 46.2 0.0 6.1 16.4 0.0 0.0 5.6 0.1 0.9 68.6 0.0 0.1 0.8 6.9 4.4 0.0 0.0 0.0 53.2 1.8 1.7 0.0 13.5 37.1 0.8 2.0 31.6 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 0.0 21.2 0.5 40.2 17.4 1.7 40.6 17.8 13.4 13.6 118.7 3.9 27.1 149.2 28.9 5.4 30.1 4.6 0.0 97.5 106.8 3.1 35.2 2.3 56.3 9.5 0.0 15.5 4.3 1.9 3.4 16.1 4.1 124.9 1.0 9.1 3.2 37.3 0.0 34.3 26.2 1.3 0.0 15.6 2.8 5.3 32.5 12.0 2.9 9.7 17.9 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991226 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "B-cells: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" NA NA Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favorable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favorable (8.20e-5)" "prognostic favorable (4.94e-9)" 13.3 8.4 2.5 15.7 2.3 12.0 7.9 1.1 3.4 17.2 12.1 3.1 20.5 6.7 26.2 22.3 15.7 8.9 9.2 5.8 2.8 2.3 26.1 8.8 14.0 14.4 3.7 1.8 11.5 4.3 1.0 4.3 10.3 3.5 15.5 7.8 9.2 9.8 16.5 9.0 5.3 14.6 13.1 4.5 17.6 6.6 5.3 2.9 16.6 13.7 9.5 20.1 18.0 15.4 16.5 10.1 12.1 12.9 6.7 7.9 6.3 3.5 2.0 0.3 4.3 10.4 13.9 3.6 4.5 9.0 8.8 14.6 1.6 3.8 7.9 7.4 5.5 8.5 5.6 2.7 4.4 5.2 8.0 1.8 3.6 3.3 1.4 13.8 4.2 7.4 13.9 3.3 5.4 1.9 7.3 7.6 3.9 2.3 4.4 10.4 1.7 4.0 4.8 1.4 0.0 2.7 6.2 4.3 8.2 10.4 7.1 0.1 0.1 3.4 7.1 12.0 0.5 1.0 5.5 7.7 1.6 2.7 2.7 3.0 5.1 3.7 8.9 4.3 5.2 9.7 10.1 10.6 4.7 7.6 12.9 7.4 14.3 6.5 6.8 10.1 16.5 6.2 6.7 12.1 6.7 11.4 9.5 7.9 6.3 2.5 2.3 1.1 3.4 2.8 2.3 3.7 1.8 3.5 2.9 23.8 43.9 100.5 47.4 13.3 0.6 3.5 22.9 17.4 29.6 43.6 0.0 19.8 14.9 19.1 0.9 42.0 39.9 0.0 13.0 17.5 17.0 35.9 34.6 14.8 28.8 0.0 17.4 27.0 84.3 2.2 18.4 61.3 10.1 49.5 29.9 0.3 17.8 40.3 17.7 62.8 0.7 6.5 18.9 0.2 0.2 8.2 17.7 36.2 23.3 78.5 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Group enriched" "Detected in many" 6 "Early spermatids: 313.3;Late spermatids: 1149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "NTERA-2: 43.2;RT4: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.9 10.6 28.7 14.5 12.6 6.8 11.6 4.5 7.1 9.0 21.1 23.8 13.9 0.0 19.1 4.6 6.2 6.5 0.1 8.6 10.6 0.0 15.4 1.4 6.9 26.5 7.0 0.0 1.1 13.3 4.2 7.9 3.1 13.1 19.1 0.0 0.0 0.0 9.2 8.2 0.0 0.1 43.2 12.0 8.0 0.0 13.6 0.0 14.1 65.2 1.8 7.8 4.5 3.9 6.0 24.1 5.7 1.0 5.3 5.6 8.6 9.2 2.9 0.0 0.0 0.0 5.0 0.0 4.0 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 3.0 8.5 7.8 36.0 6.4 0.7 7.3 61.1 115.1 21.6 89.0 0.0 26.5 19.9 64.9 313.3 22.2 51.9 0.0 11.1 33.5 17.7 46.5 0.0 94.2 3.8 0.0 32.3 58.9 11.8 1149.4 30.5 2.9 10.1 1.8 42.7 38.6 20.9 46.0 33.6 37.7 1.5 19.4 7.5 19.0 32.2 4.6 11.3 3.5 78.3 78.2 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.9 3.8 5.9 2.5 3.3 17.0 8.3 3.4 3.2 4.6 7.8 6.5 8.2 9.3 2.6 2.4 15.2 2.4 8.4 0.9 17.1 24.2 7.6 16.6 12.0 5.2 4.7 13.1 4.7 6.3 4.9 2.4 3.7 3.4 6.3 11.5 8.6 1.2 27.1 7.9 26.0 14.2 4.9 14.1 11.4 4.7 26.4 2.8 8.0 11.0 10.1 9.8 15.2 13.0 2.3 9.7 7.8 10.1 6.5 7.4 26.1 5.3 16.8 13.5 9.2 2.6 6.5 3.4 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 8.9 8.0 9.8 49.6 97.9 8.9 3.6 7.6 2.7 7.9 17.4 3.9 58.7 26.6 19.0 30.4 15.8 17.3 0.0 20.4 54.1 23.1 30.9 10.4 31.6 20.8 9.5 81.1 15.4 16.8 89.2 15.0 18.1 20.3 17.2 21.3 12.0 21.6 17.5 18.7 33.8 8.7 45.3 30.6 11.5 17.7 89.8 90.2 15.3 12.8 32.8 VASP ENSG00000125753 "Vasodilator stimulated phosphoprotein" P50552 19 45506579-45526983 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 388.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 23.6" "Group enriched" "Detected in all" 6 "granulocytes: 23.6;monocytes: 10.4" "Cell line enhanced" "Detected in all" "HMC-1: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004612, HPA005724" Enhanced Supported "Plasma membrane,Cell Junctions,Focal adhesion sites" NA NA 110000000 "Plasma membrane, Cell Junctions, Focal adhesion sites" "CAB004612: AB_2213431, HPA005724: AB_1858721" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (4.70e-2)" "unprognostic (7.85e-3)" "unprognostic (8.31e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-2)" "unprognostic (3.64e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (5.91e-7)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.08e-2)" 29.1 10.3 4.9 33.3 5.9 40.3 19.0 3.9 4.7 22.6 38.2 5.3 15.4 28.8 37.5 13.3 34.3 23.8 32.2 21.1 5.2 4.3 17.9 21.1 30.5 44.5 7.7 2.2 22.5 10.5 2.9 7.5 31.5 6.2 26.8 9.8 8.9 12.9 20.3 10.4 13.0 43.7 36.7 4.8 69.2 33.4 14.4 6.6 28.3 11.7 12.8 33.2 39.2 17.5 1.8 2.6 23.6 10.4 2.0 2.1 2.2 15.5 16.4 4.8 8.2 2.4 4.2 12.3 16.1 12.4 11.1 9.7 7.4 32.8 7.2 13.7 12.8 7.4 14.5 1.4 15.9 3.7 21.2 3.7 41.4 8.1 12.5 13.6 15.1 65.0 6.4 9.0 10.4 6.7 9.0 16.5 6.1 24.7 15.7 6.8 13.0 6.9 13.1 8.4 14.6 11.3 5.2 3.0 2.7 9.5 50.0 5.7 4.0 19.1 9.8 11.3 3.2 10.6 26.0 24.6 17.8 18.0 5.7 25.3 8.4 10.1 12.4 12.4 18.5 21.3 5.6 4.0 23.6 2.1 6.5 1.5 1.8 1.7 2.0 2.6 1.7 1.1 1.3 17.1 2.0 10.4 1.0 1.2 2.2 4.9 5.9 3.9 4.7 5.2 4.3 7.7 2.2 6.2 6.6 14.9 24.5 57.0 75.3 87.2 7.9 14.6 30.6 10.7 34.2 31.4 25.5 54.0 14.9 140.2 2.8 53.3 134.7 0.0 86.8 388.2 29.9 56.5 81.9 13.5 148.4 6.4 110.1 45.4 113.3 3.6 24.2 183.9 47.2 67.7 118.7 13.1 143.6 173.9 46.3 13.6 13.6 129.4 84.5 7.5 10.0 68.0 117.9 82.0 102.2 112.6 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 74.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 74.4 0.0 9.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 4.0 10.3 52.4 0.0 1.7 0.0 73.6 1.6 0.0 0.0 0.0 31.1 1.1 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.9 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.2 5.7 8.0 5.9 6.2 6.0 3.6 3.3 4.6 5.3 4.2 4.0 4.0 6.0 1.6 4.3 5.6 7.8 5.5 4.6 4.4 6.4 5.6 5.7 6.6 4.7 3.8 9.1 6.6 5.9 5.1 5.0 7.7 5.7 5.3 9.6 5.4 5.1 5.3 4.0 11.2 5.1 4.4 1.3 4.5 7.1 8.3 4.0 3.9 6.7 4.6 4.8 5.9 3.6 4.1 3.9 4.3 6.4 5.4 9.1 3.7 2.4 4.9 3.5 4.7 7.8 6.0 5.0 6.8 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 8.9 6.4 3.7 7.4 6.4 14.6 6.9 10.2 14.7 6.8 7.0 9.8 6.9 1.7 4.3 6.0 7.5 4.3 23.3 3.4 6.0 7.7 6.0 1.1 5.7 5.3 23.8 5.8 7.4 8.7 3.3 9.8 5.3 6.8 5.4 4.7 10.8 3.9 2.9 6.7 2.2 14.3 6.5 8.2 27.0 18.5 7.3 5.0 5.1 5.2 5.8 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 132.4;Late spermatids: 434.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.8 5.9 6.0 6.3 11.4 2.9 2.5 4.5 6.2 3.8 3.0 1.8 11.9 4.1 9.1 5.6 5.2 5.8 1.7 2.8 4.1 12.2 3.6 2.8 2.3 1.4 3.0 3.9 12.7 5.9 6.3 4.0 4.9 6.5 3.8 5.6 2.9 9.6 4.2 4.7 11.1 4.3 2.2 7.7 1.9 9.5 2.4 6.2 6.6 2.5 8.6 9.6 1.6 11.8 9.9 1.8 12.9 6.5 2.9 3.3 3.6 3.8 3.5 13.8 9.6 4.4 10.1 3.4 5.6 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 6.0 1.9 17.1 10.5 5.7 19.5 8.5 17.8 20.1 6.8 15.7 17.7 6.3 41.4 19.2 132.4 11.1 34.5 0.0 27.4 7.9 13.1 9.8 4.7 18.7 21.4 20.6 19.5 14.1 22.9 434.2 18.4 15.6 16.9 28.9 25.1 28.0 19.6 32.3 18.7 38.4 25.5 6.5 12.5 25.3 7.9 6.1 3.9 20.3 22.1 5.7